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CHAPTER I 
 
 
INTRODUCTION 
 
Escherichia coli O157:H7 was first implicated in outbreaks of disease 
linked to undercooked ground beef in the early 1980’s (49).  Cattle are a 
recognized reservoir of strains of enterohemmorhagic E. coli O157:H7 (17).  The 
infectious dose of enterohemmorhagic E. coli O157:H7 has been estimated to be 
as low as <100 cells.  Enterohemmoraghic E. coli O157:H7 infection can lead to 
hemolytic uremic syndrome which can be distinguished by hemolytic anemia, 
thrombocytopenia, and possible acute renal failure which can be fatal (32).  
Escherichia coli O157:H7 has been shown to have long-term survival in both 
manure and water (62, 63).  This can lead to contamination of both water 
supplies and crops.  Because of the risk of food or water borne illness it is 
important to find methods to reduce the carriage of E. coli O157:H7 by cattle. 
 Probiotic bacteria have been shown to promote intestinal health and 
immune function (30).  Enhancement of the immune system is one proposed 
mechanism by which probiotics may confer benefits to the host.   
Direct-fed microbials are also known as probiotics.  Both terms refer to a live and 
naturally occurring bacterial supplement (27).  The following discussion will use 
the terms “probiotics” and “direct-fed microbial” interchangeably.  Brashears et al. 
(9) reported a decrease in fecal shedding of E. coli O157:H7 for cattle fed 
Lactobacillus-based direct-fed microbials.  Younts-Dahl et al. (67) investigated 
three different doses of Lactobacillus acidophilus NP51 on reductions of E. coli 
 2
O157 in cattle.  The highest dose of NP51 resulted in the greatest decrease of E. 
coli O157 in the cattle.  An experiment by Peterson et al. (41) also confirmed the 
previous results by reporting a decrease in E. coli O157:H7 for cattle fed L. 
acidophilus NP51.     
 The objective of this experiment was to look into the mechanism by which 
direct-fed microbials decrease the prevalence of E. coli O157:H7 in live cattle.  
The steers in this experiment were inoculated with the pathogen.  One group of 
steers was fed direct-fed microbials while the other group was not.  Uncovering 
the mechanism for the decrease in pathogens in cattle fed direct-fed microbials 
may lead to the isolation of even more effective cultures. 
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CHAPTER II 
  
 
REVIEW OF LITERATURE 
 
Characteristics of Escherichia coli O157:H7:  Pathogenicity, Prevalence, and 
Other Important Considerations 
 Escherichia coli O157:H7 has received a lot of attention because of its 
connection with food and water borne illnesses.  The pathogen was first identified 
as a food borne pathogen in 1982 after an outbreak from contaminated 
hamburgers (49).  A brief history of the knowledge of E. coli O157:H7 will be 
included and information on its prevalence in cattle as well as food, water, and 
soil.   
 
Escherichia coli O157:H7 Emergence and Disease Characteristics  
Escherichia coli O157:H7 is thought to have emerged from a combination 
of events.  Virulent bacteria may have genes for toxin production, adhesins, and 
invasins that reside in certain regions of a bacterial chromosome called 
pathogenicity islands (29).  Shiga-like toxins of E. coli O157:H7 are 
bacteriophage encoded (40, 58).  New pathogens may be created from the 
horizontal gene transmission by plasmids or phages (29).  Some research 
indicates that E. coli O157:H7 was derived from an enteropathogenic E. coli 
(EPEC) ancestral strain that expressed the enzyme β-glucuronidase and had the 
ability to ferment sorbitol (24).  Escherichia coli O157:H7 contains but does not 
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express the uidA gene for the inducible enzyme β-glucuronidase (23).  This 
ancestral EPEC strain gave rise to a strain with O55 somatic and H7 flagellar 
antigens (24).  The rfb region generally contains 8 to 14 genes and encodes for 
the enzymes to produce the O side chains that characterize serogroup specificity 
(48, 59).  The O side chains or somatic antigens are part of the bacterial 
lipopolysaccharide (47, 66).  The O antigens initiate antibody responses where 
the antibody-antigen complex activates the complement system to produce 
membrane attack complex or phagocytosis (47).  Shiga-toxin 2  is thought to 
have been acquired by transduction by a toxin-converting bacteriophage.  A uidA 
+92 mutation occurred and the somatic antigen, O55, became O157.  This strain 
was a precursor to today’s E. coli O157:H7 but it still retained expression of β-
glucuronidase and sorbitol fermentation.  Further mutations led to the loss of 
sorbitol fermentation and the acquisition of Shiga-toxin 1.  The loss of β-
glucuronidase expression leads us to the current pathogenic strain (24).    
The disease caused by E. coli O157:H7 can be characterized by 
hemorrhagic colitis which causes bloody diarrhea, non-bloody diarrhea, and 
hemolytic uremic syndrome.  Strains of E. coli that cause these diarrheal 
diseases are referred to as enterohemorrhagic.  In the United States the most 
important enterohemorrhagic serotype currently is O157:H7.  Other serotypes 
such as O26 and O111 cause more problems than O157:H7 in other countries 
(32). 
Strains of enterohemorrhagic E. coli express intimin.  Intimin is required 
for attachment to the host cell and the formation of attachment/effacing lesions in 
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cattle (18, 19) and humans (43). Shiga toxin or verocytotoxin is a key virulence 
factor for enterohemorrhagic E. coli (28, 32, 60).  These strains are referred to as 
Shiga toxin-producing E. coli if they produce at least one type of Shiga toxin (28).  
It was discovered that some strains of enterohemorrhagic E. coli may produce 
Shiga-like toxins in 1982.  Extracts of toxins produced by different strains of E. 
coli were tested for cytotoxicity in HeLa cells.  The extracts were able to be 
neutralized with Shiga toxin antiserum (39).  The toxin was further characterized 
and compared to Shiga toxin in a follow up experiment.  The two toxins were 
found to have many similarities but they differed in molecular weight.  These 
results suggested to the authors that a family of Shiga-like toxins exists (40). 
There are two subgroups of Shiga toxins which are referred to as Shiga 
toxin 1 and Shiga toxin 2 (32).  In order for disease to be caused the Shiga toxin-
producing E. coli must be ingested.  It must survive the harsh, acidic environment 
of the stomach and the upper gastrointestinal tract so that it may colonize the 
lower gastrointestinal tract (60).  Renal inflammation occurs when Shiga toxin 
travels from the colon to the kidney and induces cytokine and chemokine 
production.  The damage caused by this can lead to hemolytic uremic syndrome.  
Shiga toxin can also cause damage in the colon which can result in bloody 
diarrhea and hemorrhagic colitis (32).   
 
Pre-harvest Prevalence of Escherichia coli O157:H7 in Cattle  
 Cattle are recognized as the main reservoir for E. coli O157:H7 (7, 14).  
Many studies have been conducted to determine the prevalence of E. coli 
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O157:H7 in cattle.  Five feedlots in the Midwestern United States were sampled 
for E. coli O157:H7.  The pathogen was isolated from the feces of 719 (23%) of 
the 3,162 cattle tested.  At least one animal from each of the 29 pens was 
positive.  Smith et al. (53) reported that the prevalence of cattle shedding E. coli 
O157:H7 was not significantly different among feedlots but there was a 
significant variation within feedlots.  
  In similar commercial feedlot studies the prevalence of E. coli O157:H7 
observed was different.  LeJeune et al. (34) observed that 13.3% of the fecal 
samples tested were positive.  Every pen had at least one positive sample.  The 
largest prevalence survey to date, which included cattle from the 13 states with 
the most feedlot cattle, was conducted by the USDA’s Animal and Plant Health 
Inspection Service.  The percentage of positive fecal samples was 1.8% and 
63% of the feedlots tested had at least one positive sample (3).              
The differences observed in the prevalence data in each experiment can 
be explained by several factors.  First of all the methods for detecting the 
pathogen were not standardized.  Tests conducted by different researchers may 
vary in their sensitivity to detect the pathogen (4).  Secondly, the age of the 
animal may influence infection.  Wells et al. (65) conducted an experiment of E. 
coli O157:H7 in dairy cattle and they recovered the pathogen more often in 
young animals than in adults.  Cray and Moon (15) observed that among 
experimentally infected animals, calves shed E. coli O157:H7 in greater numbers 
and for a longer time period than adult animals.  A third reason for prevalence 
differences may be the season in which the samples are taken.  Elder et al. (21) 
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observed that the peak times for E. coli O157:H7 shedding was during summer 
and early fall.    
 
Post-harvest Prevalence of Escherichia coli O157:H7 in Cattle 
 Elder et al. (21) observed what appeared to be a correlation between the 
fecal prevalence of E. coli O157:H7 and carcass contamination at slaughter.  Out 
of 29 lots of cattle tested there were 11 lots (38%) that had hides positive for the 
pathogen.  The prevalence of positive hides within lots ranged from 0% to 89%.  
There was at least one positive carcass in 27 out of 30 lots (90%).  The 
percentages of positive carcasses varied depending on the processing step.  Out 
of 30 lots the following positives occurred at three different processing steps: 26 
positives (87%) at pre-evisceration, 17 positives (57%) at post-evisceration, and 
5 positives (17%) at post-processing.   Of the 17 positive carcasses at post-
evisceration, 16 of those also were positive at the pre-evisceration step.  
 When monitoring 3 Midwestern fed-beef processing plants, Barkocy-
Gallagher et al. (5) reported that 60.6% of hide samples and 26.7% of carcass 
samples were positive for E. coli O157:H7 prior to a pre-evisceration wash.  The 
positive carcasses dropped to 1.2% after the washing step.  The researchers 
also observed that while the fecal prevalence of the pathogen peaked in the 
summer, the hide prevalence remained high from spring through the fall. 
 The variation seen in post-harvest prevalence appears to be caused by 
the same inconsistencies as the pre-harvest prevalence data.  Detection 
methods used were not standardized and therefore likely varied in sensitivity to 
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detect the pathogen.  A possible seasonal variability as previously mentioned will 
certainly affect the post-harvest prevalence as well.  Both pre-harvest and post-
harvest prevalence studies differ as a result of a lack of knowledge of the 
shedding patterns of the pathogen by cattle (34).  More research is needed to 
expand the knowledge of the behavior of this pathogen in the live animal as well 
as its survival through the slaughter process.         
 
Prevalence of Escherichia coli O157:H7 in Crops, Fresh Produce, and 
Contributing Factors 
 In recent years foodborne illnesses from fresh produce reported to the 
Centers for Disease Control and Prevention (CDC) have been increasing (52).  
Outbreaks of illness caused by E. coli O157:H7 were first reported in produce in 
1991 and they accounted for 21% of the 183 foodborne illness outbreaks (46).  
Consumption of fresh fruits and vegetables has increased in the United States so 
the potential for foodborne illnesses from these sources also has increased.    
Because cattle and other animals are reservoirs for pathogens it is 
possible that crops may become contaminated with E. coli O157:H7 through the 
use of manure as a fertilizer (31).  Contamination can also occur through 
irrigation of plants with untreated water or sewage (8, 55).  Feces from infected 
cattle may also contaminate fields of crops through surface water runoff from 
nearby cattle operations (2).   
The most recent outbreak of E. coli O157:H7 in fresh produce was from 
the consumption of fresh spinach.  The illness was reported in 199 people in 26 
 9
states between August 19 and September 5, 2006.  The people suffered from 
enteritis caused by a Shiga toxin producing strain of E. coli O157:H7.  The fresh 
spinach and other spinach products came from a company in California.  The 
exact cause of the contamination is still not known but the same strain of the 
pathogen was observed in cattle manure from cattle ranches adjacent to the crop 
fields.  Since 1993 this was at least the 26th outbreak caused by E. coli O157:H7 
in leafy green vegetables (36). 
One of the latest theories is that some crops may become tainted through 
the internalization of E. coli O157:H7 from contaminated fertilizer, irrigation water, 
or run-off water.  Escherichia coli O157:H7 has been shown to have long-term 
survival in both manure and water (62, 63).  Several studies have investigated 
whether the pathogen may enter the plant through the root system.  There are 
many factors at work but research demonstrates that E. coli can enter plants via 
the root system (31, 54, 64).   
 
Possible Solutions to Decrease the Prevalence of  
Escherichia coli O157:H7 in Cattle 
 There are many possible interventions to decrease E. coli O157:H7 in the 
live animal.  Implementing one or more of these strategies will hopefully reduce 
the levels of the pathogen in beef products.  Reduction in contamination of other 
products such as fresh produce may also result from successful pre-harvest 
intervention strategies.   
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Vaccination Against Escherichia coli O157:H7 
Vaccines against the pathogen are currently being developed and studied.  
In an experiment conducted by Potter et al. (44) a vaccination with type III 
secreted proteins derived from E. coli O157:H7 was tested on feedlot cattle.  
Type III secreted proteins are thought to be involved in the colonization of E. coli 
O157:H7 in ruminants.  Prior to vaccination the treatment and control groups did 
not differ significantly in the prevalence of shedding E. coli O157:H7.  Post-
treatment there was significantly less shedding of the pathogen in the vaccinated 
cattle pens when compared to the unvaccinated control group pens (44). 
Peterson et al. (42) also conducted an experiment investigating the use of 
a vaccine containing type III secreted proteins from E. coli O157:H7.  This 
experiment tested the following four treatments:  1) no vaccination, 2) one dose 
on day 42, 3) two doses: one on day 0 and one on day 42, and 4) three doses: 
one each on days 0, 21, and 42.  Receiving one, two, or three doses of vaccine 
resulted in cattle that were respectively 68, 66, and 73% less likely to shed the 
pathogen when compared to controls.  Some of the cattle penned with those 
given the vaccine were given a placebo treatment.  Placebo-treated steers were 
less likely to shed E. coli O157:H7 when compared to external controls that were 
not housed with vaccinated animals.  The researchers concluded that this was 
the result of reduced shedding by the vaccinated penmates.        
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Feeding Practices to Reduce Acid Resistant Escherichia coli Before Slaughter 
 Some research has indicated that feeding a high concentrate diet such as 
those fed in feedyards may contribute to the survival of acid resistant E. coli.  
Diez-Gonzalez et al. (20) conducted experiments to investigate this by feeding 
cattle diets consisting of 0, 45, or 90% grain.  The researchers observed that as 
the percentage of grain increased in the diet so did the acid resistant E. coli 
count.  In response to these findings they investigated whether a transition to a 
hay diet would decrease these populations.  After 5 days on a hay diet the E. coli 
population decreased by 106-fold.   
 The experiment by Diez-Gonzalez et al. (20) has been reported as 
contradictory in its results.  The in vivo work in the experiment by Diez-Gonzalez 
(20) tested acid resistance of generic non-serotyped E. coli.  The in vitro work 
included in the experiment tested E. coli O157:H7 and generic E. coli.   Grauke et 
al. (2003) observed that generic E. coli and pathogenic E. coli O157:H7 have 
different reactions to diet and acid shock tests.  Their experiments indicated that 
a hay or grain diet did not affect the acid resistance of E. coli O157:H7.  On the 
other hand there were higher populations of generic coliforms in grain-fed versus 
hay-fed cattle.            
 
Sodium Chlorate Supplementation to Reduce Escherichia coli O157:H7 
 The nitrate reductase activity of E. coli O157:H7 also reduces chlorate to 
chlorite which is toxic to the organism (57).  Calloway et al. (12) tested the effect 
of chlorate supplemented drinking water on cattle experimentally infected with 
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three strains of E. coli O157:H7.  They observed that the treatment reduced the 
pathogen by two logs (104 to 102) in the rumen and three logs (106 to 103) in the 
feces.   In another animal experiment with sheep Callaway et al. (13) observed 
that chlorate decreased E. coli O157:H7 in experimentally infected animals when 
compared to the control group.          
 
The Use of Direct-fed Microbials to Control the Shedding of Escherichia coli 
O157:H7 
 In vitro experiments with lactic acid bacteria have shown inhibition of 
pathogens in laboratory growth media as well as ruminal fluid and manure (10).  
The success of these experiments led to cattle experiments in order to assess 
the effects of the direct-fed microbials on pathogens in vivo.  Brashears et al. (9) 
conducted a study in which steers were fed a 90% concentrate diet with one of 
three treatments.  The control treatment had added lactose which is the carrier 
for the direct-fed microbials.  The experimental treatment animals either received 
1 x 109 CFU of Lactobacillus acidophilus NPC 747 or Lactobacillus crispatus 
NPC 750.  When averaged over time, the NPC 747 treatment showed decreased 
E. coli O157:H7 positives and was more effective than NPC 750.  There also was 
a significant decrease in E. coli O157:H7 on the hide samples.  Such reductions 
can result in less contamination of meat products.   
 A similar direct-fed microbial experiment was conducted by Peterson et al. 
(41).  A total of 448 steers (192 steers in 2002 and 256 steers in 2003) were 
randomly assigned to the treatment group that would receive L. acidophilus 
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NP51 as a daily supplement or a control group that would receive no 
supplementation.  They developed a regression model to predict the likelihood 
for shedding E. coli O157:H7.  Over the 2 year experiment they observed that the 
cattle in pens treated with NP51 were 35% less likely to shed the pathogen than 
those steers in the control pens.         
 
The Use of Direct-fed Microbials in Livestock 
   Probiotics or direct-fed microbials have been shown to provide an array 
of potential health benefits for both humans and domestic animals.  A popular 
definition was coined by Fuller (25) who stated that probiotics are “a live 
microbial feed supplement which beneficially affects the host animal by improving 
its intestinal microbial balance”.  As a dietary supplement for humans they have 
been shown to be effective for lactose maldigestion, anti-carcinogenic properties, 
control of serum cholesterol, control of intestinal pathogens, and enhanced 
immunity.  Probiotic cultures for animals and livestock have been investigated 
and are now more widely used.  Some applications for animals include inhibition 
of pathogens, enhanced immunity, increased milk yields, and improved growth 
and performance.  The following will discuss possible improvements in feed 
efficiency, milk yield, and immune responses in cattle.  The use of direct-fed 
microbials to inhibit pathogens in cattle was discussed in the previous section. 
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Direct-fed Microbial Supplementation for Calves 
 Cruywagen et al. (16) fed forty Holstein-Friesian bull calves either milk 
replacer with no additives or milk replacer with 1 ml (5 x 107) of L. acidophilus.  
The calves were assigned to one of the two treatments at two days of age and 
each treatment was given twice daily.  At seven days of age the calves were 
allowed ad libitum access to a commercial calf starter pellet.  The researchers 
measured weight, feed intake, and fecal consistency as an indication of scours.  
There were no significant differences in body weight between treatments.  
Average daily gain was significantly different between treatments during the 2nd 
week of life for the calves.  The control group lost 4% of their initial body weight 
in the first two weeks while the treatment group lost only 0.8% of initial body 
weight.  This loss of body weight is often seen in calves fed milk replacer.  The 
treatment had no effect on scours or dry matter intake.  The researchers 
concluded that the use of probiotics for calves during the first two weeks of life 
may be beneficial.  Probiotics may be especially beneficial for calves fed milk 
replacer. 
 A similar experiment with dairy calves was conducted by Abu-Tarboush et 
al. (1).  Twenty-four Holstein bull calves were assigned to one of three treatments 
at five days of age.  The treatments included:  1) control treatment with 50% 
whole milk plus 50% milk replacer, 2) whole milk and milk replacer with added L. 
acidophilus and L. plantarum (mixed lactobacilli treatment), and 3) whole milk 
and milk replacer with added L. acidophilus 27SC.  The calves received their 
liquid diet plus treatments twice daily.  In addition calves were offered a pelleted 
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starter diet ad libitum.  The researchers observed that the average daily gains 
were not significantly different between treatments.  Although not significant they 
did observe that the calves fed the mixed culture of lactobacilli had the greatest 
body weight gains during weeks 7-9 of the experiment.  The group receiving only 
L. acidophilus 27SC had the highest gains during weeks 10-12.  There was a 
significant difference between treatments when looking at the scour index for all 
sampling periods.  The scour index used was: 1 = watery, 2 = moderate, and 3 = 
normal.  The group receiving L. acidophilus 27SC had the scouring result closest 
to normal at 2.76.  The mixed culture of lactobacilli treatment group had the next 
highest at 2.69 while the control group had the lowest score of 2.55.   
 
Improved Feed Efficiency with Direct-fed Microbial Supplementation 
 Rust et al. (50) conducted a research project to test the effects of 
BovamineTM rumen culture on the performance of feedlot steers.  There were 320 
steers that were blocked by weight and assigned to one of four treatments.  The 
four treatments included: 1) water, no bacteria (control), 2) 109 cfu/g 
Propionibacterium freudenreichii (PF24) and 106 cfu/g of L. acidophilus (LA45), 
3) 109 P. freudenreichi (PF24) plus 106 cfu/g of L. acidophilus LA45 and 106 cfu/g 
of L. acidophilus LA51, and 4) 109 P. freudenreichi (PF24) plus 108 cfu/g of L. 
acidophilus LA45 and 108 cfu/g of L. acidophilus LA51.  The four treatments were 
applied to the diet in the amount of 1000 ml/pen/day and then mixed.  Each pen 
received feed once daily.  The duration of the experiment was 115 days with the 
cattle being weighed and orts collected at 28 day intervals.  After 115 days the 
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cattle were harvested and the quality and yield grades were recorded.  Cattle 
receiving any of the three microbial treatments had a 6.9% faster weight gain 
than the control group.  There were no significant differences among carcass 
weights or dry matter intake when comparing treatments. 
 Feeding increasing doses of L. acidophilus (strain NP 51) combined with a 
single dose of P. freudenreichii (strain NP 24) was tested in two feeding 
experiments by Vasconcelos et al. (61).  Two hundred forty steers were selected 
for each experiment based on body frame and body weight.  The control 
treatment contained only the lactose carrier while the other three treatments all 
had 1 x 109 cfu/(steer·day) of P. freudenreichii (strain NP 24) plus either a low, 
medium, or high dose of L. acidophilus (strain NP 51) which had 1 x 107, 1 x 108, 
or 1 x 109 cfu/(steer·day) respectively.  These treatments were used in both 
experiments but the method of feeding the treatments differed.  In experiment 1 
the freeze-dried direct-fed microbials were suspended in water and mixed with 
the diet.  In experiment 2 the freeze-dried packet of culture was mixed with 1 kg 
of air-dried corn before adding and mixing with the diet.  Blocks of cattle were 
harvested when both body weight and visual appraisal indicated that about 60% 
of the cattle would grade USDA choice.  The data from both experiments were 
pooled.  Overall the average daily gain and dry matter intake were not 
significantly different between treatments and control.  The treatments with the 
low (1 x 107) and high (1 x 109) doses of L. acidophilus NP 51 showed an 
improvement of about 2 to 3% of live-weight gain:feed.  The medium dose (1 x 
108) did not show as much of an effect on gain:feed when compared to the 
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control group.  The treatments did not affect carcass characteristics when 
compared to controls.  The researchers concluded that both the strains of direct-
fed microbials as well as the doses need to be investigated further. 
 Other studies on the use of direct-fed microbials have had results that 
were not as positive as the two previous studies mentioned.  Beauchemin et al. 
(6) conducted two different cattle experiments.  The first experiment tested 
Enterococcuss faecium in eight cannulated steers.  The second experiment 
tested the same culture as the first experiment with added yeast in eight steers 
with both ruminal and duodenal cannulas.  The two studies looked at many 
parameters including feed intake, body weight, ruminal pH and fermentation, 
microbial counts from rumen and fecal samples, digestion, and blood chemistry.  
This experiment points to the importance of bacterial species selection and their 
interaction with the diet fed.  Supplementing the cattle with E. faecium caused an 
increase in propionate but with that came some undesirable metabolic changes.  
The addition of yeast to the E. faecium decreased the undesirable changes but 
overall there was not much difference between the treatment and control groups. 
The culture used in their experiment proved to have little effect on reducing 
acidosis in cattle on a high-grain diet.  The researchers stated that E. faecium 
with or without yeast might possibly have some benefit in cattle that are not 
already adapted to high grain diets.      
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Improved Milk Yields in Dairy Cattle from Direct-fed Microbial Supplementation 
 There have been many studies conducted to investigate the effects of 
direct-fed microbials on milk production by dairy cattle.  Nocek and Kautz (38) 
studied the effects of direct-fed microbials on forty-four multiparous Holstein 
cows.  The cows were assigned to one of two treatment groups 21 +/- 3 days 
before their expected calving date.  The experiment continued through 10 weeks 
post-calving.  The control treatment consisted of a total mixed ration (TMR) with 
no direct-fed microbial supplementation prepartum or postpartum.  The 
experimental group received TMR prepartum and TMR postpartum plus an 
added 2 g of direct-fed microbials/cow/day.  The direct-fed microbial treatment 
was a commercial product called Probios TC (Chr. Hansen) which is comprised 
of 5 x 109 cfu of yeast and 5 x 109 cfu of two strains of Enterococcus faecium.  
The treatment was mixed with corn meal and then added to the feed.  The 
control group received corn meal with no added cultures.  The cows receiving the 
direct-fed microbials had increased milk production and dry matter intake when 
compared to controls.  The experimental group had a lower milk fat percentage 
than the control cows.   
 Stein et al. (56) looked at the effect of Propionibacterium P169 (P169) 
supplementation on milk yields, milk components, ruminal parameters, and 
reproductive measures of dairy cows.  Nineteen primiparous and 19 multiparous 
Holstein cow were assigned to treatments two weeks before calving.  The 
treatments consisted of the following:  1) control group received a lactation TMR, 
2) low-dose group received the control TMR with 6 x 1010 cfu/cow of P169, and 
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3) high-dose group received the control TMR with 6 x 1011 cfu/cow of P169.  The 
P169 treament was top-dressed on 4.5 kg TMR once per day.  The daily milk 
production for each cow was recorded and milk samples were collected two 
times each week for analysis.  Blood samples were taken once weekly to 
determine progesterone concentrations.  Estrous behavior of the cows was also 
monitored.  Rumen fluid samples were analyzed for concentrations of volatile 
fatty acids (VFA).  The milk production was averaged across primiparous and 
multiparous cows.  Both the low and high-dose treatment cows had significantly 
higher milk production than controls.  The percentage of fat in the milk was 
significantly higher for the low-dose and control groups.  The high-dose P169 
supplement resulted in an increase in propionate which is the most metabolically 
efficient VFA.  There were no differences observed between treatments when 
considering the reproductive measures.  It should be noted that the dosages of 
the direct-fed microbials in this experiment were exceptionally high.      
 The direct-fed microbial experiments for dairy cattle often use a variety of 
different cultures and doses.  Studies also differ in stage of pregnancy or 
lactation for which the supplements are administered.  This makes it difficult to 
determine whether direct-fed microbials as a whole provide consistent results.  
The two previously mentioned dairy cattle experiments administered probiotic 
supplements prior to calving and for either 10 weeks (38) or 30 weeks (56) 
postpartum.  In contrast to this Raeth-Knight et al. (45) administered one of three 
treatments to Holstein cows in midlactation.  The treatments used were 1) 1 x 109 
cfu/d L. acidophilus LA747 and 2 x 109 cfu/d P. freudenreichii PF24 (DFM1), 2) 1 
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x 109 cfu/d L. acidophilus LA747, 2 x 109 cfu/d P. freudenreichii PF24, and 5 x 
108 cfu/d L. acidophilus LA45 (DFM2), and 3) lactose as the control treatment.  
There were two simultaneous studies with these treatments.  Experiment one 
was a lactation study with 39 multiparous and 18 primiparous Holstein cows.  
Experiment two was a rumen fermentation study with three rumen-fistulated 
multiparous Holstein cows.  Experiment one resulted in no significant differences 
among treatments for dry matter intake, milk yields, or feed efficiency.  The 
results of experiment two showed no significant treatment differences in rumen 
pH, ammonia, or VFA.  The researchers concluded that the supplementation of 
mid-lactation cows under their experimental conditions was not beneficial when 
compared to control treatments.  The comparison of these studies provides 
further indications that the benefits of direct-fed microbials may be largely 
affected by many factors.            
 
Improved Immune Response of Cattle Fed Direct-fed Microbials 
 There is very little literature available discussing the impact of direct-fed 
microbials on the immune system of cattle.  These types of studies have been 
done on other species.  Lessard and Brisson (35) observed that pigs consuming 
a fermented product with L. bulgaricus, L. casei, and S. thermophilus had higher 
IgG levels than controls when challenged with a transmissible gastroenteritis 
virus vaccine.  Shu and Gill (51) showed that L. rhamnosus HN001 (DR20TM) 
significantly increased anti-E. coli IgA titers in mice challenged with E. coli 
O157:H7.  
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 Because of the growing interest in direct-fed microbials for cattle, 
Emmanuel et al. (22) conducted a cattle experiment to investigate immune 
responses from these supplements.  The researchers had two consecutive 
experiments with 8 cannulated steers.  The design was a 2 x 2 Latin square with 
2 periods and 2 diets in each experiment.  In experiment 1 the treatments were 
either a top-dressed control treatment or E. faecium EF212 treatment.  
Experiment 2 was very similar except the treatment group received E. faecium 
EF212 plus Saccharomyces cerevisiae (yeast).  There were 21 days in each test 
period which could be broken down into 10 days of adaptation and 11 days of 
measurement.  Blood samples were taken on days 17 and 21.  The blood 
parameters tested were serum amyloid A (SAA), lipopolysaccharide binding 
protein (LBP), haptoglobin, and alpha1-acid glycoprotein (α1-AGP).  These 
compounds are acute phase proteins which are released by the immune system 
due to inflammation, infection, or injury.  Experiment 1 resulted in no significant 
treatment effects for steers fed E. faecium when looking at plasma SAA, LBP, 
haptoglobin, and α1-AGP.  In experiment 2 the steers receiving E. faecium and 
yeast had higher plasma SAA levels than control steers.  This may be relevant 
because it is thought that SAA is involved in binding and removal of endotoxin.  
The treatment steers also had elevated LBP and haptoglobin which also 
indicates the presence of an inflammatory response.  The researchers concluded 
that the mechanisms for the increase in these proteins should be further studied.  
Whether these acute phase proteins are beneficial to the host would also require 
further investigation.         
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Characteristics of Immunoglobulins in the Ruminant System 
 The following information is an overview of the location and functions of 
IgA, IgG, and IgM in the ruminant system.  Immunoglobulins are produced in 
response to antigens that are perceived as foreign by the host organism.  
Production of antibodies represents the humoral immune system (26).  Serum 
immunoglobulins are made up mostly of IgG.  The structure of IgG consists of 
two gamma heavy chains and two kappa or lambda light chains.  Of all of the 
immunoglobulins, IgG is the most effective at complement fixation, bacterial 
agglutination, toxin neutralization, virus neutralization, and precipications (26).  
Bovine IgG can be divided into the subclasses IgG1 and IgG2.  Bovine IgG differs 
from IgG in other species in its distribution in external secretions.  
Immunoglobulin A is the more abundant immunoglobulin in the external 
secretions including colostrum and milk for humans, rats, and mice (37).  Cattle 
and other ruminants have more IgG1 in mammary secretions (26, 37) as well as 
other excretions excluding those for saliva and tear production (37).  Both bovine 
IgG1 and IgG2 have been observed to be identical in the ability to fix bovine 
complement.  They do however differ in some other functions.  The IgG2 is 
responsible for inducing both adherence and phagocytosis by neutrophils and 
monocytes (37).  In non-ruminants the intestinal secretions contain mostly IgA.  
In ruminant intestinal systems IgA comprises a large amount of the 
immunoglobulins but IgG is also present in substantial amounts (33). 
 Secretory IgA is made up of an IgA dimer which is connected by a 
covalently bonded J chain.  The dimeric IgA-J-chain complex has a strong 
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attraction for the secretory component.  The secretory component is a sizeable 
transmembrane protein made by glandular epithelial cells.  The free form of the 
secretory component is proteolytically cleaved while a portion of it remains in the 
membrane.  The part left in the membrane is a receptor for the dimeric IgA-J-
chain complex.  Once the secretory component becomes part of the complex it is 
moved across the glandular epithelial cell.  The secretory IgA is then released in 
the lumen of the secretory organ (33).  A secretory peptide remains with the IgA 
and is responsible for the resistance of secretory IgA to digestive enzymes.  This 
resistance makes secretory IgA able to stay intact in transit through the gut (26).   
 Secretory IgA and serum IgA apparently are produced by different 
cellular systems.  The B cells of the lamina propria produce secretory IgA.  
Secretory IgA appears to be of great importance for protection against pathogens 
because it can be detected on mucous membranes and most secretions.  
Secretory IgA is dimeric while serum IgA is in the monomeric form.  Serum IgA is 
not a very effective opsonin and does not activate the complement system 
except by an alternate pathway.  In rodents the hepatobiliary route is 
documented as a means to clear IgA-antigen immune complexes from serum.  It 
could be possible that this is also the case for cattle (26).   
 The first antibody to appear in the primary immune response is IgM.  It 
is nicknamed the “ancestral antibody” because it was the first antibody to appear 
phylogenetically as well as the first to appear as an animal matures from birth to 
adulthood.  Serum IgM is orientated as a circular shaped pentamer with five 
functional bivalent units.  It contains ten heavy and light chains with a small J 
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chain in the center.  It contains a total of ten antigen-binding regions and 
responds to most antigens as the most efficient complement activator.  It also is 
the most efficient at agglutinating antigens.  In some cases it can also lyse or 
damage pathogens (26).         
 Butler (11) has put together the most extensive review of bovine 
immunoglobulins to date.  Butler (11) states that bovine immunoglobulins are 
fundamentally the same as those found in other mammals and he has compiled 
the amounts of immunoglobulins in serum and many other bovine sampling sites.  
The values included are from studies, however with no standardization of 
methods.  The differing ages and breeds of cattle used in the studies may also 
influence the results.   
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ABSTRACT  
 
 
This experiment was conducted to determine if immune enhancement 
might be responsible for the success of the direct-fed microbials, Lactobacillus 
acidophilus and Propionibacterium freudenreichii, in reducing the carriage of 
Escherichia coli O157:H7 in live cattle.  Ten steers fed a pelleted growing diet ad 
libitum were assigned to one of two treatments.  Five of the steers received the 
direct-fed microbials (DFM) (1 x 109 CFU each) while the control group received 
only lactose (carrier).  Treatments were fed once daily for 21 days after which the 
animals were transported to a bovine BSL-2 barn, rectally incolulated with E. coli 
O157:H7 ATCC 43894 (10 ml of 2.0 x 107 cfu/ml), and housed in separate pens.  
The once daily treatments and ad libitum feeding were continued.  After 
inoculation the previously mentioned samples were taken every 12 hours for 48 
hours, daily until 7 days post-inoculation, and weekly until the conclusion of the 
experiment.  Feed consumption and weekly body weights were used to 
determine overall performance measures.  Performance, immunological, and 
microbial plating data were analyzed using Proc Mixed ANOVA, repeated 
measures ANOVA, and Fischer’s exact test, respectively.  A P<0.10 was 
considered significant.   The control group had a higher dry matter intake 
(P=0.06).  There were no differences in average daily gain (P=0.60) or gain to 
feed ratio (0.97) between the two groups.  The immunological results of the 
experiment showed higher levels of serum IgA for the DFM group for all post-
challenge sample times.  There were treatment (P<0.10) and day effects 
(P=0.0001) for serum IgA.  Granulocytes and granulocytes as a percentage of 
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white blood cells showed a significant treatment x day interaction (P=0.07 and 
P=0.06, respectively) with the DFM group being higher for both.  Several serum 
blood chemistry parameters had significant treatment x day interactions 
including:  BUN (P=0.02), BUN:creatinine (P=0.01), anion gap (P=0.03), total 
protein (P=0.09), albumin (P=0.02), and aspartate aminotransferase (P=0.05).  
Serum alanine aminotransferanse and alkaline phosphatase both had treatment 
effects (P=0.07 and P=0.02 respectively).  There were no significant differences 
between treatments for numbers of animals that were negative or positive for E. 
coli O157:H7 throughout the experiment.  These results suggest that feeding the 
direct-fed microbial product, Bovamine®, may have a potential to enhance the 
immune response of cattle inoculated with E. coli O157:H7.      
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INTRODUCTION 
 Escherichia coli O157:H7 first became a pathogen of concern in the early 
1980’s when it was linked to outbreaks of foodborne illness from the consumption 
of ground beef (52).  Cattle have been deemed one of the main reservoirs for the 
transmission of E. coli O157:H7 (15).  In the decades following the early 1980’s 
outbreak there have been a wide array of different and unanticipated situations 
involving the transmission of E. coli O157:H7.  Many subsequent outbreaks also 
were linked to beef products, although in 1991 some were associated with fresh 
produce (50).  Escherichia coli O157:H7 had the ability to survive in organic 
wastes that are used as fertilizers (3).  Contaminated runoff water also may 
inadvertently pollute fields of crops with the pathogen (1).  Amazingly outbreaks 
have even been linked to buildings at county fairs (20, 61) and petting zoos (12). 
 All of these various outbreaks reinforce the need for strategies to 
decrease and/or eliminate sources of E. coli O157:H7.  Because cattle have 
been linked directly or indirectly to sources of contamination they appear to be an 
important species to establish prevention strategies.  There has been a surge of 
research to investigate different methods to reduce E. coli O157:H7 in live cattle.  
Some of the strategies studied include vaccines against E. coli O157:H7 (45, 47), 
transition from a grain to hay diet prior to slaughter (17), sodium chlorate 
treatment (9, 10, 55), and direct-fed microbials for pathogen reduction (5, 44). 
 The focus of this experiment was to investigate the effect of a 
commercially available direct-fed microbial product containing a species of 
Lactobacillus and one Proprionibacterium species on the fecal shedding of E. coli 
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O157:H7 by ten steers that were rectally inoculated with the pathogen.  Five of 
the steers were fed a control treatment while the other five received the direct-fed 
microbials.  The direct-fed microbials used had been shown to cause significant 
reduction in the incidence of E. coli O157:H7 in feedlot cattle (5).  Fecal samples 
and rectal swabs were tested for E. coli O157:H7 to determine fecal shedding 
throughout the experiment.  Blood serum and fecal extracts were used to test 
IgG, IgA, and IgM at each sampling time.  Blood samples were also tested for 
serum blood chemistry and a complete blood count.  Dry matter intake, average 
daily gain, and gain efficiency also were calculated for each animal throughout 
the experiment.     
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MATERIALS AND METHODS 
 
 
Source and Maintenance of Cultures 
 Escherichia coli O157:H7 ATCC 43894 was from the food microbiology 
culture collection at Oklahoma State University.  It was subcultured weekly using 
a 1% inoculum into 10 ml of sterile tryptic soy broth (TSB) (Difco Laboratories, 
Detroit, MI) and incubated at 37°C for 18 hrs.  It w as subcultured at least three 
times on consecutive days just prior to use.  The direct-fed microbial (DFM) 
product, marketed as Bovamine®, contained L. acidophilus and P. freudenreichii, 
and was obtained from Nutrition Physiology Corp. (Guymon, OK).  Lactose was 
the carrier for the cultures in the DFM.  The culture packets (individual daily 
doses) were stored in a freezer at -20°C.  Microbial po pulations in the product 
were confirmed by plating serial dilutions of packets of the DFM on MRS agar 
(Difco Laboratories, Detroit, MI).   
 
Feeding Experiment 
 Ten 9-month-old Angus-cross steers were randomly allocated to one of 
two treatments.  The starting body weight of the control and the direct-fed 
microbial (DFM) groups were 604.0+/-13.95 and 607.6+/-13.95, respectively.  
Five of the steers received the DFM.  The five remaining steers received a 
control treatment of lactose (an amount equal to that in the DFM), which is the 
carrier for the DFM.  All of the steers were cared for and handled in accordance 
with the guidelines set by the Oklahoma State University Institutional Animal 
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Care and Use Committee (protocol # AG-07-7).  Day 0 baseline samples were 
taken prior to administration of the treatments.  The samples included the 
following:  body weight, blood samples, rectoanal mucosal swabs, and fecal 
samples.   
The steers were housed in separate pens and individually fed a pelleted 
growing diet (Table 1) ad libitum with treatments given once per day.  The 
treatments were top-dressed on the feed.  Samples were taken on day 7 and day 
14 after the start of treatments.  During the third and final week of the adjustment 
period the steers were transported to the BSL-2 bovine isolation barn at the 
Center for Veterinary Health Sciences, Oklahoma State University.  The steers 
were in the BSL-2 barn for three days before inoculation with E. coli O157:H7 
ATCC 43894.   
 On day 21 steers were sampled before they were rectally inoculated with 
E. coli O157:H7 ATCC 43894 as described by Sheng et al. (54) with a few minor 
changes.  Ten milliliters of a cell suspension of E. coli O157:H7 ATCC 43894 (2.0 
x 107 CFU/ml) was asceptically poured onto a sterile sponge in a sterile Whirl 
Pak bag (Nasco, Fort Atkinson, WI) and placed on ice for transport to the barn.  
The sponge absorbed all of the liquid culture.  One sponge was prepared for 
each animal.  After manual removal of feces with a gloved hand (Nitrile gloves, 
VWR, West Chester, PA) the sponge was inserted using a gloved hand into the 
terminal rectum of each steer.  The culture was gently squeezed out of the 
sponge inside the rectum and rubbed onto the rectoanal mucosa.  The tail of 
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each animal was then held down for 10 minutes to prevent defecation and allow 
the pathogen to associate with the rectoanal mucosa. 
 After inoculation samples were taken at 12 hour intervals including days 
21.5, 22, 22.5, and 23.  Daily samples were taken on days 24 through 28. 
Samples were then taken weekly on days 35, 42, 49, 56, and 63 which marked 
the conclusion of the experiment.  All steers were reinoculated on day 35 with a 
higher dose of 10 ml of 1.0 x 109 cfu/ml E. coli O157:H7 ATCC 43894.  An 
additional sample was taken on day 36 after the second inoculation.   
 At the conclusion of the experiment all 10 steers were cleared of E. coli 
O157:H7.  A combination of ceftiofur (1 ml per 100 lb of a 50 mg/ml ceftiofur 
product subcutaneously; Naxcel, Pfizer, Inc., New York, NY) and neomycin (22 
mg/kg orally; Agrilabs, St. Joseph, MO) was administered for three consecutive 
days.  After 3 days of antibiotics fecal samples and rectal swab samples were 
analyzed to confirm that every animal was negative for E. coli O157:H7.       
 
Steer Weights and Feed Data 
 Weekly body weights of steers were taken prior to each sampling.  
Weights of feed offered and refused were used to calculate daily dry matter 
intake.  Gain to feed ratios and average daily gains were also calculated.  The 
overall performance data were analyzed for the experiment.  (Steer number 184 
was eliminated from these calculations due to chronic bloating.) 
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Processing of Fecal and Swab Samples 
 Fecal samples were collected by manual stimulation or free catch, placed 
in a sterile Whirl-Pak bag (Nasco, Fort Atkinson, WI) and put on ice until 
processing.  Rectoanal mucosal swab samples (RAMS) were collected with a 
sterile foam-tipped swab (VWR, West Chester, PA).  The swab was inserted 3 to 
5 cm into the anus and the mucosal surface was rapidly swabbed with an in and 
out motion.  Swabs were immediately placed into 10 ml of GN broth 
supplemented with antibiotics and stored on ice. 
Swabs and fecal samples were processed using a similar procedure to 
that of Brashears et al. (5).  Briefly, ten grams of feces were asceptically added 
to 90 ml of GN-VCC broth (GN broth, Difco Laboratories, Detroit, MI), with 8 
µg/ml vancomycin (Sigma-Aldrich, St. Louis, MO), 50 ng/ml cefixime (USP, 
Rockville, MD), and 10 µg/ml cefsulodin (Sigma-Aldrich, St. Louis, MO).  Each 
rectoanal mucosal swab was added to a separate tube containing 10 ml of GN 
broth supplemented with the same concentrations of antibiotics used for the fecal 
samples.  Both sets of samples were incubated for 6 hours at 37°C.  Rather than 
immunomagnetic separation the enriched samples were immunoconcentrated 
using the Vidas I.C.E. coli O157 kit in the mini Vidas system (Biomérieux, 
Durham, NC).  Each immunoconcentrated sample was spread plated in duplicate 
onto sorbitol MacConkey agar (Difco Laboratories, Detroit, MI) supplemented 
with 4-methylumbelliferyl-β-D-glucuronide (5 mg/ml) (Sigma-Aldrich, St. Louis, 
MO), cefixime (50 µg/ml) (USP, Rockville, MD), and potassium tellurite (2.5 
µg/ml) (MP Biomedicals, Solon, OH) which will be referred to as CT-SMAC + 
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MUG.  The immunoconcentrated samples also were spread plated onto Chrom 
O157 agar (Chromagar Microbiology, Paris, France) supplemented with cefixime 
(0.025 µg/ml) (USP, Rockville, MD), cefsulodin (5 µg/ml) (Sigma-Aldrich, St. 
Louis, MO), and potassium tellurite (2.5 µg/ml) (MP Biomedicals, Solon, OH).  
Presumptive positive E. coli O157:H7 colonies on CT-SMAC + MUG appear 
colorless and non-fluorescent under UV light while positive colonies on Chrom 
O157 agar appear to be a mauve color.  The identifications of positive colonies 
were confirmed by using the GNI+ kit in the Vitek 32 system (Biomérieux, 
Durham, NC) and the RIM™ E. coli O157:H7 Latex Test (Remel, Lenexa, KS) to 
confirm the O157 and H7 antigens.     
 Another portion of fecal samples taken both pre- and post-inoculation was 
used to make a fecal extract in order to analyze immunoglobulins.  The fecal 
extraction method was performed as described by Peters et al. (43).  The 
following immunoglobulins were measured: IgA, IgG, and IgM.  An enzyme linked 
immunosorbent assay (ELISA) quantitation kit for each bovine immunoglobulin 
was used (Bethyl Laboratories, Inc., Montgomergy, TX).  The appropriate 
dilutions were determined and the manufacturer’s instructions were followed with 
one exception.  Bovine serum albumin (BSA) was eliminated from the reagents 
for measuring IgM due to cross-reactivity problems (eliminating BSA was 
suggested by Bethyl Laboratories).  The intra assay coefficient of variation for 
fecal IgA, IgG, and IgM were 4.23%, 4.30%, and 4.02% respectively.  The inter 
assay coefficient of variation for fecal IgA, IgG, and IgM were 3.31%, 4.28%, and 
6.53% respectively.  
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  Processing of Blood Samples 
 Blood samples were collected from each steer via the jugular vein at each 
sampling time.  Sterile vacutainers (BD vaccutainer, Franklin Lakes, NJ, red top) 
were used to collect the blood.  Blood samples were placed on ice after collection 
and then refrigerated overnight.  The samples were centrifuged at 3,000 x g for 
10 minutes to separate the serum.  Transfer pipets were used to transfer blood 
serum into labeled cryogenic vials.  Serum samples were stored at -80°C until 
further processing.   
A second blood sample also was taken in a vacutainer (BD vaccutainer, 
Franklin Lakes, NJ, purple top) containing EDTA (anti-coagulant) for a complete 
blood count.  These blood samples were analyzed using either a VetScan®HM2 
(Abaxis, Inc., Union City, CA) or an Abbott Cell-dyn 3500 (GMI, Inc., Ramsey, 
MN).  Complete blood counts were conducted only for the post-challenge period.  
A complete blood count for every time period post-challenge is also not available.  
The day 21 sample is just prior to the challenge with E. coli O157:H7 so it will 
serve as a baseline.   
 One vial of serum for each animal and sampling time was submitted to the 
Stillwater Medical Center for a complete blood panel using Vitros 5,1 FS system 
(Ortho Clinical Diagnostics, Raritan, NJ).  The complete blood panel was tested 
for:  glucose, blood urea nitrogen (BUN), creatinine, BUN:creatinine, sodium, 
potassium, chloride, carbon dioxide, anion gap, calcium, total protein, albumin, 
globulin, albumin:globulin, aspartate aminotransferase (AST), alanine 
aminotransaminase (ALT), alkaline phosphatase, and total bilirubin.   
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 Blood serum was also analyzed for IgA, IgG, and IgM.  An ELISA kit 
(Bethyl Laboratories, Inc., Montgomergy, TX) for each bovine immunoglobulin 
was used.  The manufacturer’s directions were followed except that bovine 
serum albumin (BSA) was not added to the reagents used for measuring IgM due 
to cross-reactivity problems (eliminating BSA was suggested by Bethyl 
Laboratories). The intra assay coefficient of variation for serum IgA, IgG, and IgM 
were 5.93%, 4.04%, and 5.86% respectively.  The inter assay coefficient of 
variation for serum IgA, IgG, and IgM were 9.68%, 6.00%, and 5.05% 
respectively.  
 
Statistical Analyses 
 Blood chemistry data as well as serum and fecal immunoglobulin data were 
analyzed using a repeated measures analysis of variance (ANOVA) with the SAS 
software (53).  The first-order autoregressive covariance structure was adopted.  
Differences were considered significant at the p<0.10 level.  The slice option was 
used when there was a significant treatment or treatment x time interaction 
(p<0.10).  Pairwise differences were not needed to separate Least squares 
means because there were only two treatments.   
 Performance data including dry matter intake, gain:feed, and average daily 
gain were analyzed using Proc Mixed ANOVA with the SAS software (53).  
Differences were considered significant at the p<0.10 level.  The slice option was 
used when there was a significant treatment or treatment x time interaction 
(p<0.10).  Pairwise differences were not needed to separate least squares 
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means because there were only two treatments.   
 The Fischer’s exact test was used to analyze microbial plating data that 
indicated whether each steer was positive or negative for E. coli O157:H7.  Data 
from both CT-SMAC + MUG agar and Chrom O157 agar were used for this 
analysis.       
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RESULTS 
 
Detection of Escherichia coli O157:H7 
 Pre-enriched fecal and swab samples were plated on both  
CT-SMAC+MUG and Chrom 0157 agars.  A steer was considered positive if a 
confirmed positive was observed on either CT-SMAC+MUG or Chrom 0157.  For 
the most part the positive and negative results for the fecal samples and swabs 
were the same for both types of media.  A steer was considered positive if the 
fecal samples and/or rectoanal swab sample was confirmed positive.  Prior to 
challenge, no steers in either group were positive for E. coli O157:H7.  During the 
day following the challenge, all five control steers were positive on one or more 
sampling days.  In the treatment group four of the five steers were positive on 
one or more days.  Due to small sample sizes, the Fischer’s exact test to analyze 
the positive and negative plating data was unable to detect any differences 
between the two treatments.  Positive and negative plating results for E. coli 
O157:H7 are included Table A1 in Appendix A.   
 
Serum Immunoglobulins 
The immunoglobulin levels were measured throughout the three week 
adjustment period (pre-challenge).  After E. coli O157:H7 inoculation the 
following sampling schedule was used:  12-Hour sampling intervals for day 21.5 
(12 hours post-challenge), 22, 22.5,  and 23, daily sampling for days 24 through 
28, and weekly sampling for the remainder of the experiment including days 35, 
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42, 49, 56, and 63.  Results for serum immunoglobulins A, G, and M are in table 
2.  
Serum IgA 
Overall serum IgA levels were different between the treatments (P<0.10) 
and days (P=0.0001).  There was no treatment x day interaction (P=0.33).  
Although the interaction was not significant overall, the DFM group had higher 
serum IgA levels for all post-challenge sampling days except day 23 (Figure 1).  
Serum IgA increased post-challenge for both groups but there was a much more 
dramatic increase for the DFM group.  Serum IgA was significantly higher in the 
DFM group on days 21.5 (P=0.08), 22.5 (P=0.05), 28 (P=0.08), and 35 (P=0.06).   
Serum IgG 
There were no overall differences between treatments (P=0.71) for serum 
IgG.  There was a day effect (P=0.002) but there was not a treatment x day 
interaction (P=0.64).  The control group’s serum IgG seemed to peak at day 21.5 
post-challenge with a higher level than the steers fed the DFM.  The DFM 
group’s serum IgG peaked at day 22.5.  Each group’s IgG levels began to 
decrease slightly after they reached their highest point during the post-challenge 
12-hour sampling period (Figure A1 Appendix A). 
Serum IgM 
 Overall there were no treatment (p=0.88) or treatment x day (P=0.66) 
effects for serum IgM.  There was a significant day effect (P<0.0001). There was 
a sharp increase in serum IgM for both groups shortly after the challenge (Figure 
A2 Appendix A). 
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Fecal Immunoglobulins 
Results for fecal immunoglobulins A, G, and M are in Table 2.  
Fecal IgA had a day effect (P=0.03) with no treatment (P=0.15) or treatment x 
day (P=0.90) effects (Figure A3 Appendix A).  Fecal IgG also had a day effect 
(P=0.01) with no treatment (P=0.51) or treatment x day (P=0.82) effects.  There 
were differences between treatments (P=0.01) and days (P=0.03) for IgM, 
although there was no treatment x day effect (P=0.90).  The control group had 
higher IgM levels on day 7 (pre-challenge) (P=0.01) and day 28 (P=0.09)   
 
Complete Blood Count 
 The complete blood count results are in Table 3.  There were day 
(P=0.001) and treatment x day (P=0.07, Figure 2A) effects for granulocytes.  
However, there was not an overall treatment effect (P=0.88).  The DFM group 
had significantly higher total granulocytes on days 22.5 (P=0.01) and 25 
(P=0.08).  The DFM group had its highest level of granulocytes on day 25 while 
the control group peaked on day 42.  Granulocytes as a percentage of white 
blood cells had day (P=0.001) and treatment x day (P=0.06, Figure 2B) effects.  
The treatments did not differ overall (P=0.92); however, the DFM group was 
significantly higher on day 23 (P=0.01).  Both groups increased from day 21 to 
day 63.  The DFM group peaked at day 23 while the control group peaked at day 
63.   
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There were day (P=0.04) and treatment x day (P<0.10, Figure 3A) effects 
for total lymphocytes.  Overall there were no treatment differences (P=0.95) for 
lymphocytes.  The lymphocytes for both groups followed similar trends except 
the DFM group had a sharp increase from day 23 to day 25 followed by a sharp 
decrease from day 25 to day 28.  Lymphocytes as a percentage of white blood 
cells had day (P=0.01) and treatment x day (P=0.02, Figure 3B) effects.  Overall 
there were no treatment differences (P=0.85); however, the control group had 
significantly higher levels on days 23 (P=0.02) and 28 (P=0.08).  The DFM group 
had decreased lymphocytes as a percentage of white blood cells until day 23 
after which they increased until the end of the experiment.  The results for the 
control group showed sharp increases and decreases between days 22 to 49.   
 The percentage of hematocrit had day (P=0.08) and treatment x day 
(P=0.06, Figure A6 Appendix A) effects but not treatment (P=0.11) effects.  The 
two groups diverged from similar decreasing percent hematocrit trends from days 
28 to 42 and days 42 to 49.  The control group increased from day 28 to 42 while 
the DFM group decreased.  The DFM group increased from day 42 to 49 while 
the control group increased from day 49 to 56.  Both groups decreased from day 
56 to 63.  The control was significantly higher at days 42 (P=0.01), 56 (P=0.02), 
and 63 (P=0.01).  Additional complete blood count parameters that were not 
statistically different between groups are in Figures A10 to A17 in Appendix A.  
Reference values for bovine complete blood count parameters are included in 
Table A2 in Appendix A.       
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Serum Blood Chemistry 
 Overall statistical results for blood chemistry are included in Table 4.  
Blood urea nitrogen (BUN) did not differ (P=0.13) for treatments.  There were day 
(P<0.0001) and treatment x day (P=0.02, figure 4A) effects.  Blood urea nitrogen 
for the DFM group remained constant from day 22.5 to day 63.  The BUN of the 
control group had a much sharper increase from days 28 to 63.  The control 
group had significantly higher BUN on days 35 (P=0.07), 42 (P=0.07), 49 
(P=0.004), and 63 (P=0.01).  Blood urea nitrogen:creatinine levels had treatment 
(P=0.002), day (P<0.0001), and treatment x day interaction (P=0.01, Figure 4B) 
effects.  The trends were similar to the BUN results.  Prior to challenge, both 
groups increased from day 0 to day 14; then decreased until day 21.5 for the 
control and day 22 for the DFM group.  Each group exhibited different degrees of 
increase in BUN post-challenge.  The DFM group leveled out at about day 25.  
The control group continued to increase with some fluctuation for the remainder 
of the experiment.  The control group had higher BUN:creatinine on days 21 
(P=0.02), 22 (P=0.07), 26 (P=0.09), 27 (P=0.02), 35 (P=0.003), 42 (P=0.01), 49 
(P=0.0002), 56 (P=0.02), and 63 (P=0.001).  
The anion gap had day (P<0.0001) and treatment x day (P=0.03, Figure 
A7 Appendix A) effects.  There was not a treatment effect (P=0.96).   The serum 
anion gap for both groups decreased throughout the experiment.  The control 
group had significantly higher anion gap levels on day 21(P=0.08) while the DFM 
group was significantly higher on days 22.5 (P=0.04) and 25 (P=0.005).  
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Serum total protein had day (P<0.0001) and treatment x day (P=0.09, 
Figure A8 Appendix A) effects.  There was no overall treatment difference 
(P=0.32).  The control group had significantly higher total protein on day 14 
(P=0.04).  Serum albumin had significant day (P<0.0001) and treatment x day 
(P=0.02, Figure A9 Appendix A) effects.  Serum albumin had no overall treatment 
significance (P=0.44).  Both groups had fluctuating serum albumin but there was 
an overall decrease throughout the experiment.  The control group had 
significantly higher serum albumin on day 14 (P=0.09). 
The enzyme aspartate aminotransferase had treatment (P=0.03), day 
(P=0.03), and treatment x day (P=0.05, Figure 5) effects.  The aspartate 
aminotransferase levels were similar for both groups until day 35, at which time 
the control group had a sharp increase.  After day 35 the control group’s levels of 
this enzyme decreased but the last measurement taken on day 63 was still 
higher than all measurements taken before day 35.  The control group had 
statistically higher aspartate aminotransferase on days 35 (P<0.0001), 42 
(P=0.004), and 49 (P=0.01).   
Serum alanine aminotransferase had treatment (P=0.07, Figure 6) and 
day (P<0.0001) effects.  There was not a treatment x day interaction effect 
(P=0.14).  The control group had statistically higher levels on days 21.5 (P=0.03), 
22 (P=0.06), 35 (P=0.04), and 63 (P<0.10).   
Serum alkaline phosphatase had both a treatment (P=0.02, Figure 7) and 
day (P=0.07) effect but no treatment x day interaction effect (P=0.52).  The 
control group had statistically higher levels on days 23 (P=0.08), 24 (P=0.05), 25 
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(P=0.07), 26 (P=0.08), 27 (P=0.06), 28 (P=0.07), 42 (P=0.005), and 49 (P<0.10).  
Additional serum blood chemistry parameters that were not statistically different 
between treatments are in Figures A18 to A27 in Appendix A.  Reference values 
for bovine blood chemistry analytes are included in Table A2 in Appendix A.       
     
Steer Performance 
The control group had a higher dry matter intake from the beginning to the 
end of the experiment (P=0.06).  There was no difference in overall average daily 
gain between the two groups (P=0.60).  There was also no difference in overall 
gain efficiency between groups (P=0.97). 
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DISCUSSION 
 
 The direct-fed microbial containing L. acidophilus and P. freudenreichii 
used in the current experiment has previously been shown to reduce fecal 
shedding of E. coli O157:H7 in cattle.  Brashears et al. (5) observed that cattle 
fed L. acidophilus NPC 747 were 49.0% less likely to be positive for the pathogen 
compared to control animals.   These decreases contributed to significantly less 
positive hides when comparing control animals to treatment animals.  This strain 
of L. acidophilus is the same strain that is included in Bovamine® (based on 
information from the supplier, Nutrition Physiology Corporation, Guymon, OK).  
The history of this strain is included in the Appendix B.   
 Lactobacillus acidophilus NP51 is yet another alias for the L. 
acidophilus culture included in Bovamine®.  Younts-Dahl et al. (66) observed that 
cattle fed L. acidophilus NP51 at a level of 109 CFU per steer resulted in the 
largest decreases in shedding E. coli O157.  This experiment also included 
Propionibacterium freudenreichii (NP24) at 109 CFU per steer for each treatment.  
The Bovamine® product includes this same strain of P. freudenreichii that was 
used in the experiment by Younts-Dahl et al. (66) (personal communication with 
Dr. Mindy Brashears, Texas Tech University).   
 The decision to inoculate the steers rectally with E. coli O157:H7 came 
about based on recent research that indicates that the pathogen preferentially 
colonizes the rectoanal junction (RAJ) (40).  Prior to these findings the colon had 
been identified as the principle site of colonization for E. coli O157:H7 (30).  The 
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protocol for inoculating the steers in the present experiment was adapted from an 
experiment by Sheng et al. (54).  The rectal inoculation of the experiment by 
Sheng et al. (54) resulted in long-term colonization of the cattle.  In the current 
experiment all of the steers started out negative for E. coli O157:H7.  The steers 
were first inoculated with a 10 ml cell suspension (2.0 x 107 cfu/ml) of the same 
strain of E. coli O157:H7 used in some experiments included in an experiment by 
Sheng et al. (54).  We did not observe the uniform pathogen colonization as was 
described by Sheng et al. (54).  Both fecal samples and rectoanal mucosal 
swabs (RAMS) were tested for the presence of this pathogen.  There were 
differences observed in the numbers of positive animals between the two sample 
types but overall the results from fecal and swab samples were similar.  
Experiments have been conducted solely to compare RAMS and fecal samples 
for detecting E. coli O157:H7.  These experiments indicate that RAMS are more 
sensitive for detection (51).  This supports the findings that E. coli O157:H7 
preferentially colonizes the RAJ (40).  Naylor et al. (40) observed high levels of 
tissue-associated E. coli O157:H7 proximal to the RAJ.  The uneven distribution 
of the pathogen in the fecal samples of these animals led them to conclude that 
the bacteria had only coated the surface of the fecal material as it was excreted.  
Another factor may be that RAMS are not inundated with fecal material that 
contains many other types of bacteria (51).  Rice et al. (51) also sampled 
naturally colonized animals with RAMS and fecal samples.  They observed that 
some animals had positive RAMS but negative fecal samples.  This suggests 
that the animals may be harboring the pathogen but not shedding it.  Similar 
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situations may have occurred in the present experiment resulting in inconsistent 
occurrence of positive samples.   
 The differences in culture positive steers in the current experiment and 
that of Sheng et al. (54) may be explained by differences between the two 
experiments.  Sheng et al. (54) had a low-dose group (1.0 x 107 CFU E. coli 
O157:H7 ATCC 43894) and a high-dose group (109 CFU of a four-strain mixture 
with equal parts of: ATCC 43894, WSU 180, WSU 400, and WSU 588).  In the 
current experiment, we used only E. coli O157:H7 ATCC 43894.  Strain ATCC 
43894 was isolated from an outbreak of hemmorhagic colitis in Michigan (63).  
Strains WSU 180, WSU 400, and WSU 588 used by Sheng’s group were 
cultured from cattle (54).  Sheng et al. (54) made no conclusions concerning the 
use of a 1.0 x 107 CFU dose of a single culture compared to the use of a 1.0 x 
109 CFU dose a four-strain mixture.  They also made no mention of any effects 
due to the origin of the strain.  Wells et al. (64) identified ground beef products as 
the culprit in causing the outbreak of hemmorhagic colitis in Michigan.  It could 
then be presumed that the ATCC 43894 strain actually may have originated from 
cattle since it appeared in the ground beef.  Therefore in this case the origin of 
the strain may not have necessarily differed as to influence the colonization of 
the cattle.  It might be helpful in future research to investigate if and why using a 
high dose of multiple strains of E. coli O157:H7 affects successful long-term 
rectal colonization of cattle.        
 The sampling periods for the experiments were also very different.  
Sheng et al. (54) sampled days 0, 7, 14, 22, 29, 36, 44, 58, and 66 for the high-
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dose group and days 0, 6, 13, 20, 27, 34, 41, 48, and 55 for the low-dose group.  
In the current experiment a more intense sampling schedule was used because 
of efforts to detect changes in immune response.  It might be argued that 
sampling this often could skew results because too much of the pathogen could 
be manually removed during the sampling and limit its ability to maintain 
colonization.  This seems unlikely though because most fecal samples in the 
present experiment were collected by a free catch method and did not have to be 
invasively collected.  It is also unlikely that the swabs used for sampling would 
interfere with pathogen persistence throughout the experiment.  Sheng et al. (54) 
tested the effects of repeated rectal swabbing on colonization and observed that 
it had no effect.   
 The two experiments also differed somewhat in the methods for 
detecting E. coli O157:H7.  In the present experiment plating non-enriched 
samples yielded no E. coli O157:H7 positive colonies on the CT-SMAC + MUG or 
Chrom O157 agars.  Sheng et al. (54) were able to detect E. coli O157:H7 by 
direct plating for many samples.  When they were not able to detect by direct 
plating they used an enrichment procedure that differed slightly from the present 
experiment.  Sheng et al. (54) used TSB broth supplemented with cefixime, 
potassium tellurite, and vancomycin while the present experiment used GN broth 
with added vancomycin, cefixime, and cefsulodin.  GN broth, Hajna is used as an 
enrichment medium to recover enteric Gram-negative bacilli (18).  In both studies 
enrichment cultures were plated on SMAC agar but the added antibiotics differed 
somewhat.  Sheng et al. (54) added cefixime, potassium tellurite, vacomycin, and 
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MUG to the media while the present experiment used SMAC agar with added 
MUG, cefixime, and potassium tellurite.  Cefixime is used to inhibit Proteus spp. 
which are sorbitol non-fermenters like E. coli O157:H7 (13).  Vancomycin inhibits 
the growth of Gram-positive bacteria (39).  Potassium tellurite is included in 
selective media because it is well documented that most strains of E. coli 
O157:H7 contain one or more copies of a tellurite resistance gene (58).  In both 
experiments the addition of MUG served as a differential agent for colonies 
negative for glucuronidase.  Escherichia coli O157:H7 is negative for both 
sorbitol fermentation (42) and glucuronidase (23).  Therefore the colonies appear 
colorless and do not fluoresce under a UV light when plated on SMAG agar with 
added MUG.  The slight differences in enrichment and culturing procedures 
should not be enough to affect the overall results.  
 Inconsistencies in direct-fed microbial studies previously reported make 
it difficult to compare the immunoglobulin analyses in the present experiment.  
Previous direct-fed microbial experiments have mainly evaluated cattle 
performance, carcass characteristics, and carriage of E. coli O157:H7.  These 
types of experiments rarely look at immune parameters.  Recently the area of 
immune enhancement related to direct-fed microbials has been receiving 
increased attention.  This is due to the thought that an increased immune 
response is possibly the mode or one of the modes of action by which direct-fed 
microbials decrease pathogen carriage in cattle.  Elam et al. (21) measured 
serum IgA in one of the two experiments included in their study.  The blood 
samples to measure serum IgA were collected at the time of slaughter and at no 
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other time period.  The researchers used the same basic ELISA method that was 
used in the present experiment but observed no differences.  In the present 
experiment there was not a significant treatment x day interaction but the DFM 
group had higher serum IgA levels for all post-challenge sampling times.  This 
included a post-challenge increase of a much higher magnitude than the control 
group which would suggest an increased immune response. 
 The serum immunoglobulin results for IgA and IgM obtained in the 
present experiment fall within the range among the mean values compiled from 
the various studies included in the review by Butler (8).  Interestingly the serum 
IgM levels in the present experiment peaked on day 22.  This is the only time 
period that the values rise slightly above the previously mentioned range among 
means values in Butler’s (8) report.  This peak may have been observed 
relatively soon after the challenge with E. coli O157:H7 because IgM has been 
shown to be the first immunoglobulin to appear during an immune response (27).  
Of the serum immunoglobulins, IgG is the most abundant followed by IgM and 
the least abundant serum immunoglobulin is IgA.  A table in the review by Butler 
(8) includes the range among the mean values of immunoglobulin concentrations 
from the studies included.  This same table includes the amounts of IgG1 and 
IgG2 in biological fluids.  In the present experiment the ELISA procedure used 
made no differentiation between the two subclasses of IgG.  The total serum IgG 
from the present experiment corresponds to the amounts listed for serum in the 
table when the values for IgG1 and IgG2 are combined. 
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  The serum IgG and IgM levels observed in the present experiment are 
similar to the value listed by Gershwin et al. (27).  The serum IgA levels were 
similar for the most part but in several instances they were lower than the value 
reported by Gershwin et al. (27).  As previously mentioned any differences could 
very well result from the values being obtained from different breeds of cattle as 
well as age and sex variations and methods of immunoglobulin analyses.  
 In the present experiment fecal immunoglobulins were measured in 
efforts to get an idea of influence of the direct-fed microbial on intestinal or 
mucosal immunity.  There are different opinions on the use of fecal extracts to 
measure mucosal immunity.  Ferguson et al. (24) reported that the use of fecal 
extracts to quantify immunoglobulins can be inaccurate and misleading.  The 
researchers came to this conclusion by comparing fecal extract immunoglobulins 
to immunoglobulins measured by using whole gut lavage fluid.  The 
inconsistencies observed in using fecal extracts led the researchers to conclude 
that gut humoral immunity should only be measured by whole gut lavage, 
segmental gut perfusion, intestinal fluid aspiration, and biopsy.  
 McNeilly et al. (38) conducted an experiment in which they determined 
some effective methods for measuring bovine mucosal immunity.  The 
researchers determined that both nasal secretions and rectal swabs are effective 
in sampling for mucosal immunity.  They also determined that these same 
samples could be used for antigen-specific immunoglobulins such as the H7 
flagellin-specific antibodies detected in their experiment.   
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 In the present experiment the fecal immunoglobulin ELISA raw data 
results appeared to be quite variable.  However, the standard errors for the 
overall stastical analysis of the fecal immunoglobulins were not particularly high.  
There were no statistical differences for fecal IgA and IgG.  There was an overall 
treatment difference for fecal IgM.  The two sampling days on which these 
differences occurred do not appear to be the result of an immune response.  The 
control group had significantly higher fecal IgM on day 7 which was prior to the E. 
coli O157:H7 challenge.  The other difference occurred on day 28 post-
challenge.  Immunoglobulin M is the first antibody to respond in an immune 
response (27).  The serum immunoglobulin results indicated an increase 
immediately after the challenge.  The same might be expected from measures of 
intestinal immunity since the pathogen mainly colonizes at the terminal rectum 
(40).  It is difficult to verify whether or not the results correspond to any previous 
research due to the many different methods and sample preparations used in the 
limited research available.  The fecal immunoglobulin results from the present 
experiments are much lower than the rectal swab immunoglobulins reported by 
McNeilly et al. (38).  The fecal IgA and IgG results are 10 to 100-fold and 100 to 
1000-fold lower respectively than the results for the rectal swabs by McNeilly et 
al. (38).  In retrospect it may have been more useful in the present experiment to 
have a more accepted and verified method for measuring mucosal immunity in 
cattle.  In addition to this it also may have be useful to test for immunoglobulins 
that are antigen-specific to the pathogen used for the challenge.   
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 The complete blood count results indicated that total granulocytes were 
significantly higher in the DFM group on days 23 and 25.  Granulocytes as a 
percentage of white blood cells were significantly higher in the DFM group on day 
23.  The more dramatic increase in granulocytes post-challenge in the DFM 
group may be in efforts to control the inoculated E. coli O157:H7.  Granulocytes 
and mononuclear cells are part of a group of cell types called leukocytes or white 
blood cells.  Granulocytes can be broken down into neutrophils, eosinophils, and 
basophils (34).  Research has shown that bovine granulocytes lack lysozyme.  
Granulocytes can phagocytize invading microorganisms.  In vitro studies with 
lysates from bovine granulocytes have been shown to kill E. coli and 
Staphylococcus aureus (26).  Neutrophils make up the highest number of 
circulating granulocytes.  They are phagocytic and generally first to respond to an 
inflammation site (60).         
 Lymphocytes had a slightly significant treatment x day interaction but 
there were no significant differences between treatments at each sampling day.  
The biggest difference between the groups occurred on day 25.   The DFM group 
was higher than the control group although not significant.  The increase in 
lymphocytes for the DFM group on day 25 was the highest increase post-
challenge for either group.  This may be an indication of an increased immune 
response in the DFM group post-challenge.  The total lymphocytes for the two 
groups were fairly similar for all other sampling times.  There was no significant 
treatment x day interaction for white blood cells but lymphocytes as a percentage 
of white blood cells were significantly higher for the control group on days 23 and 
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28.  The DFM group had a sharp increase in total white blood cell count on day 
25 that corresponded with increases in granulocytes and lymphocytes on the 
same day.  This makes sense because both granulocytes and lymphocytes are 
types of leukocytes or white blood cells.   With the exception of lymphocytes all 
white blood cell types are produced and mature in bone marrow.  Bone marrow 
stem cells produce lymphocytes which mature and replicate in lymphoid tissues 
(34).  Lymphocytes and macrophages are the two cell types that are implicated in 
an immune response and make up what is termed the lymphoreticular system.  
Lymphocytes and the cell subpopulations they give rise to have specific immune 
responses such as production of humoral antibodies for targeted agents and 
specified responses to foreign tissue antigens.  Both B cells and T cells are 
derived from the differentiation of lymphocytes (27).  Assays to quantify B and T 
cell proliferation may be useful in future work of this type. 
 The control group had significantly higher percentages of hematocrit on 
days 42, 56, and 63 but the values were not out of the reference range of 24-
46% (34).  It does not appear that the percent hematocrit differences were 
clinically significant because they were well within the reference range and 
cannot be readily explained by other factors. 
 The mean square estimates for each blood chemistry parameter for 
both groups were compared to reference ranges for normal bovine blood 
analytes.  The blood analytes that had significant treatment and/or treatment x 
day effects will be discussed in more detail than those that were not.  Those 
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values that were not significant will be discussed only if they were outside of the 
reference ranges.   
 Blood serum glucose for both groups exceeded the reference range of 
45-75 mg/dl (49) during the adjustment period.  The values were also higher than 
the reference range for a majority of sampling times post-challenge.  Serum 
albumin was within 2.1-3.6 g/dl (49).  Serum albumin had a significant treatment 
x day interaction but only day 14 during the adjustment period was significantly 
different.  Both groups showed roughly the same trends for serum albumin.  
These results appear to be clinically insignificant.  Globulin levels exceeded the 
reference range of 3.0-3.5 g/dl (36) for all sampling times.  The albumin to 
globulin ratio was only slightly lower or higher than the range of 0.84-0.94 (36) at 
a few sampling times.  Total protein stayed within the range of 5.7-8.1 g/dl (49).  
Total protein was only significantly different between the groups on day 14 of the 
adjustment period.  This makes sense because the serum albumin was also only 
significantly different at this sampling day.  Serum albumin is the most abundant 
of the serum proteins (35).     
 The BUN:Creatinine levels were very similar between the two groups 
during the adaptation period.  The BUN:Creatinine levels were significantly 
higher for the control group on day 21 just prior to E. coli O157:H7 inoculation.  
The DFM group had a lower ratio of BUN to creatinine throughout the remainder 
of the experiment.  It was significantly lower post-challenge on days 22, 26, 27, 
35, 49, 56, and 63.  Blood urea nitrogen measurements were significantly lower 
in the DFM group on days 49 and 63.  The values were not outside the reference 
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range of 6.0-27 mg/dl (49) at any sampling time.  Blood urea nitrogen and serum 
creatinine measurements are used as an indication of nitrogen waste retention in 
the kidneys.  Ruminant microflora may utilize more urea than the microflora of 
non-ruminants.  This should be taken into consideration when interpreting BUN 
levels and the subsequent BUN to creatinine ratio (25).  A possible explanation 
for the differences in BUN and BUN:creatinine in the present experiment may be 
the lower feed intake of the DFM group.  Both of these measures began to be 
increasingly different towards the end of the experiment.  It was also towards the 
end of the experiment that the dry matter intake of the two treatments began to 
noticeably differ.   
 The anion gap was significantly higher for the control group on day 21 
and higher for the DFM group on days 22.5 and 25.  The anion gap is measured 
as the difference between the cations, sodium and potassium, and the anions, 
chloride and bicarbonate.  This measure can be useful in diagnosing acid-base 
disorders of animals (11).  In the present experiment the difference in anion gap 
is not clinically significant. 
 Alanine aminotransferase (ALT) for both treatment groups exceeded 
the reference range of 11-40 units/L (49) starting at the day 7 pre-challenge 
sample.  Both groups continued to be higher than the reference range for all time 
points until the DFM group fell slightly below the upper limit of the range on day 
63.  Day 63 is the last sampling time for the experiment.  The control group had 
higher ALT levels on days 21.5, 22, and 35.  Alanine aminotransferase is the 
enzyme responsible for the transamination of L-alanine to pyruvate and 2-
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oxoglutarate to glutamate.  The transamination is reversible and occurs in the cell 
cytoplasm (37).  Alanine aminotransferase is used for diagnosing hepatic 
necrosis in small animals and primates.  It is not used in larger animals because 
their livers contain such small amounts of ALT (14). 
 Aspartate aminotransferase (AST) was significantly higher in the control 
group on days 35, 42, and 49.  From day 28 to day 35 the control group’s levels 
for this enzyme had a sharp increase.  This enzyme is responsible for catalyzing 
the reaction to convert L-aspartate and 2-oxoglutarate to oxaloacetate and 
glutamate respectively through transamination (37).  The serum levels of AST 
serve as a marker for soft tissue damage because the enzyme is found in so 
many tissues (4).  Creatine kinase is a more specific marker for muscle damage.  
Today there are organ-specific enzymes that are used more often than AST.  As 
mentioned before, AST is found in many tissues so therefore it cannot be used 
as an organ-specific enzyme (37).  A reference range for bovine serum AST is 
78-132 units/L (49).  In the present experiment all of the values were within this 
range.  It should be noted that the control group closely approached this upper 
limit on day 35.  There are no readily apparent reasons for why these values 
differed between groups towards the end of the experiment.  
 Serum alkaline phosphatase levels differed on days 23, 24, 25, 26, 27, 
28, 49, and 56 with the control group being higher.   Alkaline phosphatase 
enzymes are isoforms that hydrolyze phosphate esters.  The dephosphorylation 
of ATP is catalyzed by alkaline phosphatase.  Animals have both tissue-
unspecific and steroid-induced hepatic isoforms of alkaline phosphatase.  In the 
 65
serum of animals the tissue-unspecific alkaline phosphatase predominates.  
Measured alkaline phosphatase values in horses and ruminants may be of little 
significance because of the broad range of reference values available (37).  The 
values observed in the current experiment were well within the wide reference 
range of 0-500 units/L (49).  Adawi et al. (2) conducted an experiment to 
investigate Lactobacillus supplementation with and without arginine in an acute 
liver injury model in rats.  Some of the treatments resulted in a large decrease in 
AST and ALT when compared to the acute liver injury control group.  Alkaline 
phosphatase was also decreased in some treatment groups but to a lesser 
extent than AST and ALT.  The rat model may not be directly comparable to a 
bovine model but more investigation into the possible decrease of liver enzymes 
with Lactobacillus supplementation may be needed.  This may or may not be a 
possible explanation for the decreases in these enzymes in the present 
experiment.  As mentioned previously serum ALT, AST, and alkaline 
phosphatase are not useful markers of liver damage in cattle (13, 36, 37).    
 In the current experiment the control group had a higher overall dry 
matter intake.  No differences between groups were observed for overall average 
daily gain and gain efficiency.  Elam et al. (21) conducted two direct-fed microbial 
studies with varying combinations of treatments and days on feed.  Both 
experiments used different combinations of L. acidophilus NP51, L. acidophilus 
NP45, and P. freudenreichii NP24. Propionibacterium species use lactate and 
glucose to produce acetate and propionate (28).  Daily supplementation of 
lactate utilizing with or without lactate producing direct-fed microbials may 
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improve feed efficiency and average daily gains for cattle fed high concentrate 
rations (28).  This is also the same strain of P. freudenreichii that is included in 
Bovamine®.  The cattle in experiments in their study were on feed for 104-170 
days.  They noted that there were no significant differences in overall dry matter 
intake (DMI), average daily gain (ADG), or gain:feed.   
 Vasconcelos et al. (61) also observed no differences in DMI or ADG in 
a cattle experiment that used the same direct-fed microbials as the current 
experiment.  The researchers included P. freudenreichii strain NP24 in each of 
the three experimental treatments at 1 x 109 cfu/(steer.day).  The difference in the 
three treatments was an increasing dose of L. acidophilus NP51: low = 1 x 107, 
medium = 1 x 108, and high = 1 x 109 cfu/(steer.day).  They did find a significant 
difference in gain efficiency (live weight basis) when they averaged results from 
the three doses of L. acidophilus and compared them to the control.  The 
extremely small sample sizes and relatively short days on feed most likely limited 
a thorough look at the performance possibilities in the current experiment.       
  In recent years there has been much research on different colonization 
factors for E. coli O157:H7 in cattle.  The exact mechanism by which cattle 
become transient carriers is unknown.  Determining these colonization 
requirements will greatly advance the progress for developing successful 
vaccines and other intervention strategies.  This knowledge will also aid in 
developing more successful colonization models for cattle.   Pruinboom-Brees et 
al. (48) investigated whether tissues from cattle contain the Shiga toxin (Stx) 
receptor globotriaosylceramide (Gb3).  Thin layer chromatography of calf tissues 
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failed to detect Gb3 in the gastrointestinal tract.  Gb3 was detected in kidney and 
brain tissues.  Immunohistochemical methods were used to detect Stx1 and Stx2 
binding in a variety of tissue samples in calves and adult cattle.  These methods 
did not detect Stx binding in ileum and large intestine samples. 
 Naylor et al. (40) conducted studies with different colonization models 
including inoculation via stomach tube, oral inoculation, and a naturally colonized 
animal from a commercial beef operation.  The orally inoculated steer was used 
as a “Trojan” steer to expose other steers to the pathogen in a group pen.  The 
researchers hypothesize that an interaction between a bacterial adhesin and an 
epithelial cell receptor may be responsible for the bacterial tropism for the RAJ.  
Close analysis of the RAJ showed high concentrations of lymphoid follicles.  
Other Enterobacteriaceae such as Salmonella typhimurium, Listeria 
monocytogenes, and Shigella flexneri, also invade lymphoid follicles but the 
tropism is for those in Peyer’s patches via M cells (33).  Research indicates that 
intimin which is expressed by enterohemmorhagic E. coli O157 is required for 
attachment to human Peyer’s patches (46).   Intimin is also a requirement for the 
attachment to epithelial cells and the formation of attachment/effacing lesions in 
cattle (15, 16).  
 An experiment by Hoffman et al. (31) indicated that shiga-toxigenic E. 
coli O157:H7 infection can suppress antigen-specific cellular immune responses 
in cattle.  These findings may better explain the colonization and carriage of the 
pathogen by cattle.  A reduced or delayed antigen-specific cellular immune 
response may help support colonization of the pathogen in cattle.  Further 
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research is needed to determine how the suppression of these cellular immune 
responses effects the duration and amount of shedding of E. coli O157:H7.  
 Future studies on direct-fed microbials might involve using quantitative 
real-time PCR-based methods to quantify the amount of E. coli O157:H7 in 
artificially colonized or naturally colonized animals.  The results of this could be 
used to verify the success of colonization and serve as additional information for 
more traditional media-related detection methods.  Quantitative real-time PCR 
may be useful when the pathogen is only detectable by enrichment methods.  
This would be useful because enrichment methods only give the result for 
whether or not the pathogen is present.  It may also be beneficial to quantify 
direct-fed microbial strains in fecal or other biological samples using specific 
primers designed for the strain to be detected.  This information could verify the 
success of colonization in the animal from ingesting the direct-fed microbials.
 The advent of PCR-based methods to determine the components of 
complex microbiological systems has certainly expanded the field of knowledge 
for microbial diversity.  Identification of microorganisms in complex systems such 
as bovine rumen fluid has previously been limited by microorganisms that are 
unculturable by standard methods.  This problem may also make it difficult to 
accurately describe the distributions of the rumen and gut microbiota.  The uses 
of targeted genes that come mostly from ribosomal RNA greatly increased the 
ability to examine these population distributions (59).  Several other methods 
such as restriction fragment length polymorphisms have been developed since 
this type of work first began.  Despite these great achievements no method is 
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without limitations.  Wintzingerode et al. (65) have summarized many of the steps 
in procedures that could lead to biased and inaccurate results.  Some of these 
crucial steps include sample collection, storage, and preparation.  Cells must be 
lysed in order to extract DNA for PCR experiments.  Gram-positive bacteria 
require more meticulous methods to disrupt their thick cell wall than Gram-
negative bacteria.  In a mixed sample the more severe methods to lyse Gram-
positive cells can lead to fragmented nucleic acids from Gram-negative cells.  
These fragments can lead to erroneous results.  On the other hand if the lysing 
methods are not rigorous enough then there may be insufficient lysing of many 
microorganisms present.  Cells that do not lyse or lyse insufficiently will bias the 
final population distribution results (65).  This point became evident in some 
preliminary lab work related to the present experiment.  One of the Bovamine® 
cultures, P. freudenreichii, proved to be very difficult to lyse in pure culture.  This 
led to doubts that this culture could be effectively lysed in cattle fecal samples for 
any PCR-based analysis in the future.  Special attention would need to be paid to 
issues such as this so that an effective method may be developed.    
 Other future work in this area could include the measurement of 
antibodies to Esp and Tir proteins that are secreted by E. coli O157:H7.  These 
proteins are a critical part of the formation of A/E lesions.  Antibodies to these 
proteins and to O157 LPS have been detected in adult beef cattle that were 
inoculated with E. coli O157:H7 (6).  Peripheral blood mononuclear cell (PBMC) 
stimulation assays can give an indication of the lymphocyte proliferation in 
response to infection (31).  Measuring these antibodies and PBMC proliferation 
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in inoculated cattle with and without direct-fed microbials may help to explain the 
mode of action for the direct-fed microbials.    
 The current experiment did suggest a tendency toward increased 
immune response in the DFM group.  This was indicated by the statistically 
significant increase in granulocytes and the continued incidence of serum IgA 
being more elevated in the DFM group after challenge with E. coli O157:H7.  In 
addition to this there also were some tendencies for serum immunoglobulins to 
be higher in the DFM group even though not significant.  The marked increase in 
lymphocytes and total white blood cells may also be an indication of a 
heightened immune response, although not statistically significant.  As 
mentioned previously, a well-designed and verified method for testing mucosal 
immunity would be much better for more accurately testing mucosal 
immunoglobulins.   Conducting a similar experiment with a much larger sample 
size should bring out treatment differences more clearly.  The ability to find 
differences in this experiment was definitely limited by its small sample size.  
Conducting a large scale experiment of this type would need to be carefully 
designed because the cost of such an experiment could be immense.  Certainly 
a much larger experiment involving a challenge with E. coli O157:H7 would be 
very difficult because of the necessity of using BSL-2 facilities.  More research in 
this area is needed because E. coli O157:H7 can not only be found as a beef 
contaminant but also as a contaminant in fresh fruits, vegetables, and water.  
Determining effective procedures to minimize this is paramount.  There is not one 
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definitive intervention for this problem but rather the implementation of several 
preventative measures is necessary.                   
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Figure legends 
 
FIGURE 1.  Effects of Direct-fed microbials (DFM) and Escherichia coli O157:H7 
on serum IgA levels of steers.  Days 0, 7, 14, and 21 represent pre-challenge 
samples.  Values plotted represent Least squares means ± standard error of the 
mean (5 animals per treatment).  a,bSuperscripts between treatments on the 
same day are significantly different (Trt P<0.10).   
 
FIGURE 2A.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on total blood granulocytes levels of steers.  Day 21 represents pre-
challenge sample.  Values plotted represent Least squares means ± standard 
error of the mean (5 animals per treatment).  a,bSuperscripts between treatments 
on the same day are significantly different (P<0.10). 
 
FIGURE 2B.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on granulocytes as a percentage of white blood cells in steers.  Day 21 
represents pre-challenge sample.  Values plotted represent Least squares 
means ± standard error of the mean (5 animals per treatment).  a,bSuperscripts 
between treatments on the same day are significantly different (P<0.10). 
 
FIGURE 3A.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on total blood lymphocytes levels of steers.  Day 21 represents pre-
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challenge sample.  Values plotted represent Least squares means ± standard 
error of the mean (5 animals per treatment).   
 
FIGURE 3B.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on lymphocytes as a percentage of white blood cells in steers.  Day 21 
represents pre-challenge sample.  Values plotted represent Least squares 
means ± standard error of the mean (5 animals per treatment).  a,bSuperscripts 
between treatments on the same day are significantly different (P<0.10).   
 
FIGURE 4A.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on serum blood urea nitrogen (BUN) levels in steers.  Days 0, 7, 14, 
and 21 represent pre-challenge samples.  Values plotted represent Least 
squares means ± standard error of the mean (5 animals per treatment).  
a,bSuperscripts between treatments on the same day are significantly different 
(P<0.10).   
 
FIGURE 4B.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 on serum BUN:creatinine in steers.  Days 0, 7, 14, and 21 represent 
pre-challenge samples.  Values plotted represent Least squares means ± 
standard error of the mean (5 animals per treatment).  a,bSuperscripts between 
treatments on the same day are significantly different (P<0.10). 
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FIGURE 5.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
on serum aspartate aminotransferase levels in steers.  Days 0, 7, 14, and 21 
represent pre-challenge samples.  Values plotted represent Least squares 
means ± standard error of the mean (5 animals per treatment).  a,bSuperscripts 
between treatments on the same day are significantly different (P<0.10). 
 
FIGURE 6.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
on serum alanine aminotransferase levels in steers.  Days 0, 7, 14, and 21 
represent pre-challenge samples.  Values plotted represent Least squares 
means ± standard error of the mean (5 animals per treatment).  a,bSuperscripts 
between treatments on the same day are significantly different (P<0.10). 
 
FIGURE 7.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
on serum alkaline phosphatase levels in steers.  Days 0, 7, 14, and 21 represent 
pre-challenge samples.  Values plotted represent Least squares means ± 
standard error of the mean (5 animals per treatment).  a,bSuperscripts between 
treatments on the same day are significantly different (P<0.10). 
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Component Percentage on a dry matter basis
Wheat midds 37.6363
Alfalfa pellets 25.0000
Cottonseed hulls 15.0000
Soybean hulls 15.0000
Soymeal 47.7 3.0000
Cane molasses 3.0000
Salt 0.2500
Calcium carbonate 0.5500
Ammonium sulfate 0.5000
Selenium 600 0.0380
Vitamin A-30,000 0.0203
Vitamin E-50% 0.0027
Zinc sulfate 0.0022
Zinc oxide 0.0005
Nutrient Mcal/kg
Net energy maintenance 1.4780
Net energy gain 0.8172
Crude protein, % (x100) 0.1618
Calcium, % (x100) 0.0079
Table 1.  Composition of diet used in cattle feeding experiment.
 Table 2.  Effect of Direct-fed Microbials and Escherichia coli O157:H7 Challenge on Serum and Fecal IgA, IgG, and IgM in Steers 
Immunoglobulin   
Treatment 
SEM2 
P-values 
Control1 DFM1 Trt Day Trt x Day 
Serum IgA (µg/ml) 192.15 258.01 26.20 0.10 0.0001 0.33 
Serum IgG (mg/ml) 27.40 27.9 1.00 0.71 0.002 0.64 
Serum IgM (mg/ml) 3.36 3.31 0.20 0.88 <0.0001 0.66 
 Fecal IgA (µg/ml) 1.19 0.88 0.15 0.15 0.03 0.89 
Fecal IgG (ng/ml) 50.72 42.57 8.70 0.51 0.01 0.82 
Fecal IgM (ng/ml) 191.13 135.25 14.61 0.01 0.03 0.90 
1Least squared means; control = no direct-fed microbials, DFM = direct-fed microbials  
2Standard error of the mean 
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 Control1 DFM1 Trt Day Trt x Day
White blood cells (WBC) (x103/µl) 11.75 11.78 0.84 0.98 0.001 0.27
Granulocytes (x103/µl) 2.75 2.80 0.2 0.88 0.001 0.07
Granulocytes % of WBCs 23.56 23.75 1.29 0.92 0.001 0.06
Lymphocytes (x103/µl) 8.34 8.28 0.71 0.95 0.04 0.10
Lymphocytes % of WBCs 70.88 70.52 1.34 0.85 0.01 0.02
Mean platelet volume 7.10 6.86 0.15 0.29 0.17 0.98
Monocytes (x103/µl) 0.66 0.68 0.07 0.88 <0.0001 0.63
Monocytes % of WBCs 5.61 5.73 0.53 0.87 <0.0001 0.39
Red blood cell (RBC) count 7.98 8.21 0.22 0.47 0.02 0.88
Platelet count (103/µl) 0.55 0.37 0.09 0.19 <0.0001 0.52
Platelet count % of RBCs 0.36 0.20 0.08 0.21 <0.0001 0.55
Platelet distribution width 36.09 34.78 0.54 0.12 0.87 0.78
Hemoglobin (g/dl) 11.67 11.14 0.18 0.06 <0.0001 0.58
Mean corpuscular hemoglobin concentration(g/dl) 31.28 30.65 0.5 0.40 0.64 0.76
% hematocrit 35.33 34.28 0.44 0.11 0.08 0.06
2Standard error of the mean
Table 3.  Effects of Direct-fed Microbials and Escherichia coli O157:H7 challenge on Complete Blood Count in Steers.
Measurement  
Treatment P-values
SEM2
1Least squared means; control = without direct-fed microbials, DFM = direct-fed microbials 
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 Control1 DFM1 Trt Day Trt x Day
Glucose (mg/dl) 76.47 75.66 1.09 0.6100 <0.0001 0.4661
BUN (mg/dl) 16.13 15.08 0.46 0.1300 <0.0001 0.0246
Creatinine (mg/dl) 1.30 1.42 0.07 0.2900 0.0500 0.1213
BUN:Creatinine 12.53 10.64 0.36 0.002 <0.0001 0.01
Sodium (mmol/L) 139.66 139.81 0.22 0.61 <0.0001 0.89
Potassium (mmol/L) 5.27 5.33 0.06 0.44 <0.0001 0.28
Chloride (mmol/L) 102.39 102.22 0.27 0.66 <0.0001 0.92
Carbon dioxide (mmol/L) 23.91 24.37 0.25 0.21 <0.0001 0.25
Anion Gap 18.57 18.55 0.21 0.96 <0.0001 0.03
Calcium (mg/dl) 10.25 10.19 0.10 0.70 <0.0001 0.55
Total Protein (g/dl) 7.07 6.96 0.07 0.32 <0.0001 0.09
Albumin (g/dl) 3.29 3.24 0.05 0.44 <0.0001 0.02
Globulin (g/dl) 3.78 3.73 0.05 0.50 <0.0001 0.67
Albumin:Globulin 0.87 0.87 0.01 0.92 0.02 0.38
Aspartate aminotransferase  (U/L) 88.96 78.63 3.18 0.03 0.03 0.05
Alanine aminotransferase (U/L) 46.53 42.89 1.31 0.07 <0.0001 0.14
Alkaline Phosphatase (U/L) 76.41 63.20 3.69 0.02 0.07 0.52
Total Bilirubin (mg/dl) 0.32 0.20 0.06 0.12 0.03 0.11
2Standard error of the mean
SEM2
Table 4.  Effects of Direct-fed Microbials and Escherichia coli O157:H7 Challenge on Blood Chemistry in Steers.
Measurement  
Treatment P-values
1Least squared means; control = no direct-fed microbials, DFM = direct-fed microbials 
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 P-value
Control
1
DFM
1
Trt
Dry Matter Intake (kg) 9.24 8.06 0.39 0.06
Average Daily Gain (kg) 1.42 1.24 0.25 0.60
Gain to Feed Ratio 0.15 0.15 0.03 0.97
2Most conservative standard error of the mean; control n=5, DFM n=4.
Table 5.  Effect of Direct-fed Microbials and Escherichia coli O157:H7 Challenge on Overall Steer Performance
Measurement  
Treatment
SEM
2
1Least squared means; control = no direct-fed microbials, DFM = direct-fed microbials 
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APPENDIX A 
Additional Results Tables and Figures 
 
 
 
 
 
 
 Day 34 98 190 300 647 173 184 203 651 881
0 negative negative negative negative negative negative negative negative negative negative
7 negative negative negative negative negative negative negative negative negative negative
14 negative negative negative negative negative negative negative negative negative negative
21 negative negative negative negative negative negative negative negative negative negative
21.5 negative negative negative positive positive negative positive negative positive positive
22 positive negative negative negative positive positive negative negative positive positive
22.5 negative positive negative negative positive positive negative negative positive positive
23 positive positive negative negative positive positive negative negative positive positive
24 negative positive negative negative positive positive negative negative negative positive
25 negative positive negative negative positive positive negative negative negative positive
26 negative positive negative negative positive positive negative negative negative positive
27 negative positive negative negative positive positive negative negative negative positive
28 positive positive negative positive positive positive negative negative negative positive
35 positive positive positive positive positive positive positive negative negative positive
42 positive positive negative negative positive negative positive negative negative positive
49 negative positive negative negative positive negative positive negative negative positive
56 negative negative negative negative negative negative negative negative negative positive
63 negative negative negative negative negative negative negative negative negative negative
Table A1. Microbial testing of fecal and swab samples from each steer to detect Escherichia coli  0157:H7  
1positive for fecal and/or swab samples
2Positives confirmed using the Vitek 32 system (Biomérieux, Durham, NC) RIM™ E. coli O157:H7 Latex Test (Remel, Lenexa, KS)
Control steers1,2 Direct-fed microbial steers1,2
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Blood Parameter Reference Value
Glucose (mg/dl)1 45-75
BUN (mg/dl)1 6.0-27
Creatinine (mg/dl)1 1.0-2.0
Sodium (mmol/L)1 132-152
Potassium (mmol/L)1 3.9-5.8
Chloride (mmol/L)1 95-110
Carbon dioxide (mmol/L)2 21.2-32.2
Anion Gap (mEq/L)1 14-26
Calcium (mg/dl)1 9.7-12.4
Total Protein (g/dl)1 5.7-8.1
Albumin (g/dl)1 2.1-3.6
Globulin (g/l)2 30.0-34.8
Albumin:Globulin2 0.84-0.94
Aspartate aminotransferase  (U/L)1 78-132
Alanine aminotransferase (U/L)1 11-40
Alkaline Phosphatase (U/L)1 0-500
Total Bilirubin (mg/dl)2 0.01-0.5
White blood cells (WBC) (per µl)1 4,000-12,000
Neutrophil (per µl) (type of granulocyte)3 600-4,000
Eosinophil (per µl) (type of granulocyte)3 0-2,400
Basophil (per µl) (type of granulocyte)3 0-200
Lymphocytes (per µl)1 2,500-7,500
Lymphocytes % of WBCs3 45-75
Monocytes (per µl)1 25-800
Red blood cell count (RBC) (x106/µl)1 5.0-10.0
Platelet count (103/µl)3 100-800
Hemoglobin (g/l)2 80-150
% hematocrit or packed cell volume (%)3 24-46
1Radostits et al. 2007. A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs, and Goats.
2Kaneko, J. J. (ed.). 1989.  Clinical Biochemistry of Domestic Animals
3Feldman, B.F., J.G. Zinkl, and N.C. Jain (Eds). 2000. Shalm's Veterinary Hematology
Table A2. Normal Bovine Blood Chemistry and Complete Blood Count Values
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 Figure A1.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
Challenge on Blood Serum IgG Levels in Steers (Days 0, 7, 14, and 21 are pre-
challenge).    
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Figure A2.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum IgM Levels in Steers (Days 0, 7, 14, 
and 21 are pre-challenge). 
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Figure A3.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Fecal IgA Levels in Steers (Days 0, 7, 14, and 21 are 
pre-challenge). 
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Figure A4.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Fecal IgG Levels in Steers (Days 0, 7, 14, and 21 
are pre-challenge). 
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Figure A5.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Fecal IgM Levels in Steers (Days 0, 7, 14, and 21 are 
pre-challenge).  a,bSuperscripts between treatments on the same day are 
significantly different (Trt P<0.10). 
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 Figure A6.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
Challenge on Blood Percent Hematocrit in Steers (Days 21 is pre-challenge).  
a,bSuperscripts between treatments on the same day are significantly different (Trt 
P<0.10). 
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Figure A7.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Anion Gap in Steers (Days 0, 7, 
14, and 21 are pre-challenge).  a,bSuperscripts between treatments on 
the same day are significantly different (Trt P<0.10). 
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 Figure A8.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Total Protein in Steers (Days 0, 7, 14, 
and 21 are pre-challenge).  a,bSuperscripts between treatments on the 
same day are significantly different (Trt P<0.10). 
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 Figure A9.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Albumin in Steers (Days 0, 7, 14, and 21 
are pre-challenge).  a,bSuperscripts between treatments on the same day are 
significantly different (Trt P<0.10). 
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 Figure A10.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Total White Blood Cell Count (WBC) in Steers (Day 
21 is pre-challenge). 
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 Figure A11.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Mean Platelet Volume in Steers (Day 21 
is pre-challenge). 
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Figure A12A.  Effects of Direct-fed Microbials (DFM) and Escherichia 
coli O157:H7 Challenge on Total Blood Monocytes in Steers (Day 21 
is pre-challenge). 
 
Figure A12B.  Effects of Direct-fed Microbials (DFM) and Escherichia 
coli O157:H7 Challenge on Blood Monocytes as a percentage of 
white blood cells in Steers (Day 21 is pre-challenge). 
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Figure A13.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Total Red Blood Cell Count in Steers (Day 21 is 
pre-challenge). 
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Figure A14A.  Effects of Direct-fed Microbials (DFM) and 
Escherichia coli O157:H7 Challenge on Blood Platelet Count in 
Steers (Day 21 is pre-challenge). 
 
Figure A14B.  Effects of Direct-fed Microbials (DFM) and 
Escherichia coli O157:H7 Challenge on Blood Platelet Count as a 
Percentage of Red Blood Cells in Steers (Day 21 is pre-
challenge). 
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Figure A15.  Effects of Direct-fed Microbials (DFM) and Escherichia 
coli O157:H7 Challenge on Blood Platelet Distribution Width in Steers 
(Day 21 is pre-challenge). 
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 Figure A16.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Hemoglobin in Steers (Day 21 is pre-
challenge).  a,bSuperscripts between treatments on the same day are 
significantly different (Trt P<0.10). 
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 Figure A17.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Mean Corpuscular Hemoglobin 
Concentration in Steers (Day 21 is pre-challenge). 
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 Figure A18.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Glucose in Steers (Days 0, 7, 14, and 
21 are pre-challenge). 
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 Figure A19.  Effects of Direct-fed Microbials (DFM) and Escherichia coli O157:H7 
Challenge on Blood Serum Creatinine in Steers (Days 0, 7, 14, and 21 are pre-
challenge). 
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 Figure A20.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Sodium in Steers (Days 0, 7, 14, and 
21 are pre-challenge). 
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 Figure A21.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Potassium in Steers (Days 0, 7, 14, and 
21 are pre-challenge). 
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 Figure A22.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Chloride in Steers (Days 0, 7, 14, and 
21 are pre-challenge). 
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 Figure A23.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Carbon Dioxide in Steers (Days 0, 7, 14, 
and 21 are pre-challenge). 
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 Figure A24.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Calcium in Steers (Days 0, 7, 14, and 21 
are pre-challenge). 
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 Figure A25.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Globulin in Steers (Days 0, 7, 14, and 
21 are pre-challenge). 
 122 
 
0.75
0.8
0.85
0.9
0.95
1
0 7 14 21 21.5 22 22.5 23 24 25 26 27 28 35 42 49 56 63
A
lb
u
m
in
:G
lo
b
u
li
n
Day
Control
DFM
 Figure A26.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Albumin to Globulin Ratio in Steers 
(Days 0, 7, 14, and 21 are pre-challenge). 
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Figure A27.  Effects of Direct-fed Microbials (DFM) and Escherichia coli 
O157:H7 Challenge on Blood Serum Total Bilirubin in Steers (Days 0, 7, 14, 
and 21 are pre-challenge). 
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History of Lactobacillus acidophilus strain in Bovamine® 
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History of the isolation of the Lactobacillus acidophilus strain in Bovamine®  
This particular L. acidophilus culture was isolated in 1978 at 
Oklahoma State University.  The source of the culture was the ileum of a 
Holstein calf.  At that time the strain was designated L. acidophilus 381-IL-
28.  It has been licensed to Nutrition Physiology Corporation for their 
exclusive commercial use.  Other strain designations used in journal 
articles include L. acidophilus 747 and NP51 (Based on information 
supplied by Nutrition Physiology Corporation, Guymon, OK). 
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